
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B3B9C9264EE133C3B9C00360AD5EC.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontonco">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8417726/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Oncology">
<meta name="citation_title" content="Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers">
<meta name="citation_author" content="Yosr Hamdi">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Laboratory of Human and Experimental Pathology, Institut Pasteur de Tunis, Tunis, Tunisia">
<meta name="citation_author" content="Najah Mighri">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Maroua Boujemaa">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Nesrine Mejri">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Sonia Ben Nasr">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia">
<meta name="citation_author" content="Mariem Ben Rekaya">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="UR17ES15, Oncotheranostic Biomarkers, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Olfa Messaoud">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Hanen Bouaziz">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia">
<meta name="citation_author" content="Yosra Berrazega">
<meta name="citation_author_institution" content="Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Haifa Rachdi">
<meta name="citation_author_institution" content="Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Olfa Jaidane">
<meta name="citation_author_institution" content="Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia">
<meta name="citation_author" content="Nouha Daoud">
<meta name="citation_author_institution" content="Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Aref Zribi">
<meta name="citation_author_institution" content="Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia">
<meta name="citation_author" content="Jihene Ayari">
<meta name="citation_author_institution" content="Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia">
<meta name="citation_author" content="Houda El Benna">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Soumaya Labidi">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Jamel Ben Hassouna">
<meta name="citation_author_institution" content="Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia">
<meta name="citation_author" content="Abderazzek Haddaoui">
<meta name="citation_author_institution" content="Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia">
<meta name="citation_author" content="Khaled Rahal">
<meta name="citation_author_institution" content="Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia">
<meta name="citation_author" content="Farouk Benna">
<meta name="citation_author_institution" content="Department of Radiation Oncology, University of Tunis, Tunis, Tunisia">
<meta name="citation_author" content="Ridha Mrad">
<meta name="citation_author_institution" content="Department of Human Genetics, Charles Nicolle Hospital, Tunis, Tunisia">
<meta name="citation_author" content="Slim Ben Ahmed">
<meta name="citation_author_institution" content="Faculty of Medicine of Sousse Department of Medical Oncology Farhat Hached University Hospital University of Sousse, Sousse, Tunisia">
<meta name="citation_author" content="Hamouda Boussen">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author" content="Samir Boubaker">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_author_institution" content="Laboratory of Human and Experimental Pathology, Institut Pasteur de Tunis, Tunis, Tunisia">
<meta name="citation_author" content="Sonia Abdelhak">
<meta name="citation_author_institution" content="Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia">
<meta name="citation_publication_date" content="2021 Aug 20">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="674965">
<meta name="citation_doi" content="10.3389/fonc.2021.674965">
<meta name="citation_pmid" content="34490083">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8417726/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8417726/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8417726/pdf/fonc-11-674965.pdf">
<meta name="description" content="Breast cancer is the world’s most common cancer among women. It is becoming an increasingly urgent problem in low- and middle-income countries (LMICs) where a large fraction of women is diagnosed with advanced-stage disease and have no access to ...">
<meta name="og:title" content="Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Breast cancer is the world’s most common cancer among women. It is becoming an increasingly urgent problem in low- and middle-income countries (LMICs) where a large fraction of women is diagnosed with advanced-stage disease and have no access to ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8417726/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8417726">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fonc.2021.674965"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fonc-11-674965.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8417726%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8417726/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8417726/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8417726/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontonco.gif" alt="Frontiers in Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Oncology" title="Link to Frontiers in Oncology" shape="default" href="http://www.frontiersin.org/oncology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Oncol</button></div>. 2021 Aug 20;11:674965. doi: <a href="https://doi.org/10.3389/fonc.2021.674965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fonc.2021.674965</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Identification of Eleven Novel <em>BRCA</em> Mutations in Tunisia: Impact on the Clinical Management of <em>BRCA</em> Related Cancers</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamdi%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yosr Hamdi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yosr Hamdi</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>2</sup>Laboratory of Human and Experimental Pathology, Institut Pasteur de Tunis, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hamdi%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yosr Hamdi</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mighri%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Najah Mighri</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Najah Mighri</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mighri%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Najah Mighri</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boujemaa%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Maroua Boujemaa</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Maroua Boujemaa</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boujemaa%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maroua Boujemaa</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mejri%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Nesrine Mejri</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Nesrine Mejri</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mejri%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nesrine Mejri</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Nasr%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sonia Ben Nasr</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sonia Ben Nasr</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Nasr%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonia Ben Nasr</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Rekaya%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mariem Ben Rekaya</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mariem Ben Rekaya</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>5</sup>UR17ES15, Oncotheranostic Biomarkers, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Rekaya%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariem Ben Rekaya</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Messaoud%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Olfa Messaoud</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Olfa Messaoud</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Messaoud%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Olfa Messaoud</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bouaziz%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Hanen Bouaziz</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Hanen Bouaziz</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>6</sup>Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bouaziz%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hanen Bouaziz</span></a>
</div>
</div>
<sup>1,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Berrazega%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yosra Berrazega</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yosra Berrazega</span></h3>
<div class="p">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Berrazega%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yosra Berrazega</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rachdi%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Haifa Rachdi</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Haifa Rachdi</span></h3>
<div class="p">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rachdi%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haifa Rachdi</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jaidane%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Olfa Jaidane</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Olfa Jaidane</span></h3>
<div class="p">
<sup>6</sup>Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jaidane%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Olfa Jaidane</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Daoud%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Nouha Daoud</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Nouha Daoud</span></h3>
<div class="p">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Daoud%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nouha Daoud</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zribi%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Aref Zribi</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Aref Zribi</span></h3>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zribi%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aref Zribi</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ayari%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Jihene Ayari</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Jihene Ayari</span></h3>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ayari%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jihene Ayari</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El%20Benna%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Houda El Benna</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Houda El Benna</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El%20Benna%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Houda El Benna</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Labidi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Soumaya Labidi</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Soumaya Labidi</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Labidi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Soumaya Labidi</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Hassouna%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Jamel Ben Hassouna</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Jamel Ben Hassouna</span></h3>
<div class="p">
<sup>6</sup>Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Hassouna%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jamel Ben Hassouna</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haddaoui%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Abderazzek Haddaoui</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Abderazzek Haddaoui</span></h3>
<div class="p">
<sup>4</sup>Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haddaoui%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Abderazzek Haddaoui</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rahal%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Khaled Rahal</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Khaled Rahal</span></h3>
<div class="p">
<sup>6</sup>Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rahal%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Khaled Rahal</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Benna%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Farouk Benna</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Farouk Benna</span></h3>
<div class="p">
<sup>7</sup>Department of Radiation Oncology, University of Tunis, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Benna%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Farouk Benna</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mrad%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Ridha Mrad</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Ridha Mrad</span></h3>
<div class="p">
<sup>8</sup>Department of Human Genetics, Charles Nicolle Hospital, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mrad%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ridha Mrad</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Ahmed%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Slim Ben Ahmed</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Slim Ben Ahmed</span></h3>
<div class="p">
<sup>9</sup>Faculty of Medicine of Sousse Department of Medical Oncology Farhat Hached University Hospital University of Sousse, Sousse, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ben%20Ahmed%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Slim Ben Ahmed</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boussen%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Hamouda Boussen</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Hamouda Boussen</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boussen%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamouda Boussen</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boubaker%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Samir Boubaker</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Samir Boubaker</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">
<sup>2</sup>Laboratory of Human and Experimental Pathology, Institut Pasteur de Tunis, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boubaker%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Samir Boubaker</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdelhak%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Sonia Abdelhak</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Sonia Abdelhak</span></h3>
<div class="p">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdelhak%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonia Abdelhak</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia</div>
<div id="aff2">
<sup>2</sup>Laboratory of Human and Experimental Pathology, Institut Pasteur de Tunis, Tunis, Tunisia</div>
<div id="aff3">
<sup>3</sup>Medical Oncology Department, Abderrahman Mami Hospital, Faculty of Medicine Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div id="aff4">
<sup>4</sup>Department of Medical Oncology, Military Hospital of Tunis, Tunis, Tunisia</div>
<div id="aff5">
<sup>5</sup>UR17ES15, Oncotheranostic Biomarkers, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia</div>
<div id="aff6">
<sup>6</sup>Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia</div>
<div id="aff7">
<sup>7</sup>Department of Radiation Oncology, University of Tunis, Tunis, Tunisia</div>
<div id="aff8">
<sup>8</sup>Department of Human Genetics, Charles Nicolle Hospital, Tunis, Tunisia</div>
<div id="aff9">
<sup>9</sup>Faculty of Medicine of Sousse Department of Medical Oncology Farhat Hached University Hospital University of Sousse, Sousse, Tunisia</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Zodwa Dlamini, University of Pretoria, South Africa</p></div>
<div class="fn" id="fn2"><p>Reviewed by: Yan Du, Fudan University, China; Umamaheswaran Gurusamy, University of California, San Francisco, United States</p></div>
<div class="fn" id="fn001">
<sup>✉</sup><p class="display-inline">*Correspondence: Yosr Hamdi, <span>yosr.hamdi@pasteur.tn</span></p>
</div>
<div class="fn" id="fn002"><p>This article was submitted to Cancer Epidemiology and Prevention, a section of the journal Frontiers in Oncology</p></div>
<div class="fn" id="fn003"><p>†These authors have contributed equally to this work</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Mar 2; Accepted 2021 Jul 27; Collection date 2021.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2021 Hamdi, Mighri, Boujemaa, Mejri, Ben Nasr, Ben Rekaya, Messaoud, Bouaziz, Berrazega, Rachdi, Jaidane, Daoud, Zribi, Ayari, El Benna, Labidi, Ben Hassouna, Haddaoui, Rahal, Benna, Mrad, Ben Ahmed, Boussen, Boubaker and Abdelhak</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8417726  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34490083/" class="usa-link">34490083</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Breast cancer is the world’s most common cancer among women. It is becoming an increasingly urgent problem in low- and middle-income countries (LMICs) where a large fraction of women is diagnosed with advanced-stage disease and have no access to treatment or basic palliative care. About 5-10% of all breast cancers can be attributed to hereditary genetic components and up to 25% of familial cases are due to mutations in <em>BRCA1</em>/2 genes. Since their discovery in 1994 and 1995, as few as 18 mutations have been identified in <em>BRCA</em> genes in the Tunisian population. The aim of this study is to identify additional <em>BRCA</em> mutations, to estimate their contribution to the hereditary breast and ovarian cancers in Tunisia and to investigate the clinicopathological signatures associated with <em>BRCA</em> mutations.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>A total of 354 patients diagnosed with breast and ovarian cancers, including 5 male breast cancer cases, have been investigated for <em>BRCA1/2</em> mutations using traditional and/or next generation sequencing technologies. Clinicopathological signatures associated with <em>BRCA</em> mutations have also been investigated.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>In the current study, 16 distinct mutations were detected: 10 in <em>BRCA1</em> and 6 in <em>BRCA2</em>, of which 11 are described for the first time in Tunisia including 3 variations that have not been reported previously in public databases namely <em>BRCA1</em>_c.915T&gt;A; <em>BRCA2</em>_c.-227-?_7805+? and <em>BRCA2</em>_c.249delG. Early age at onset, family history of ovarian cancer and high tumor grade were significantly associated with <em>BRCA</em> status. <em>BRCA1</em> carriers were more likely to be triple negative breast cancer compared to <em>BRCA2</em> carriers. A relatively high frequency of contralateral breast cancer and ovarian cancer occurrence was observed among <em>BRCA</em> carriers and was more frequent in patients carrying <em>BRCA1</em> mutations.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p>Our study provides new insights into breast and ovarian cancer genetic landscape in the under-represented North African populations. The prevalence assessment of novel and recurrent <em>BRCA1/2</em> pathogenic mutations will enhance the use of personalized treatment and precise screening strategies by both affected and unaffected North African cancer cases.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> <em>BRCA</em> cancers, genetic testing, novel <em>BRCA</em> mutations, clinicopathological signatures, precision medicine</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Breast cancer is the most common malignancy among women worldwide (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>). Incidence and mortality rates of breast cancer differ between populations (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>). In Tunisia, it remains the most common cancer among females and represents the first leading cause of cancer mortality among women. The mean age at diagnosis of Tunisian breast cancer cases is around 50 years old, a decade younger than Western countries (<a href="#B2" class="usa-link" aria-describedby="B2">2</a>, <a href="#B3" class="usa-link" aria-describedby="B3">3</a>).</p>
<p><em>BRCA1</em> and <em>BRCA2</em> are the most prominent breast cancer susceptibility genes that convey high risk of breast and ovarian cancers (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>). Since their discovery, a wide range of mutational spectrum have been described for both genes. So far, more than 1800 distinct <em>BRCA1</em> and 2000 <em>BRCA2</em> mutations have been reported in the Breast Cancer Information Core (BIC) database. These mutations explain around 20-30% of breast cancer genetic component and seem to be associated with different other cancers such as prostate, pancreatic, endometrial and melanoma (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>). The identification of novel <em>BRCA1/2</em> mutations has important clinical implications. Indeed, unaffected <em>BRCA</em> mutation carriers have various preventive options including extensive and regular surveillance, chemoprevention, and risk-reducing surgery (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>–<a href="#B8" class="usa-link" aria-describedby="B8">8</a>), while, affected cases carrying <em>BRCA</em> mutations could benefit from personalized therapeutic options such as platinum-based chemotherapy and poly (ADP-ribose) polymerase (PARP) inhibitors (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>, <a href="#B10" class="usa-link" aria-describedby="B10">10</a>). However, a full <em>BRCA1</em> and <em>BRCA2</em> gene screening remains a labor and time-consuming challenge due to the large gene size, diverse mutations, or variants of unknown significance (VUS) and complexity of large genomic rearrangements (LRs) and copy number variations (CNVs) requiring special technical approaches. Recent advances in high throughput sequencing technologies including Target panels and whole exome sequencing (WES) allowed rapid, sensitive, and cost-effective screening of the large <em>BRCA</em> genes. In addition, the decreased cost of genotyping and sequencing offered affordable targeted testing options.</p>
<p>Sequencing thousands of cancer samples showed that the frequency of germline mutations in <em>BRCA</em> genes varies widely among populations. Some mutations are shared between different populations and others are ethnic specific (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>, <a href="#B12" class="usa-link" aria-describedby="B12">12</a>). Indeed, in certain countries and ethnic communities, the <em>BRCA</em> mutation spectrum is limited to a few founder mutations (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>, <a href="#B14" class="usa-link" aria-describedby="B14">14</a>). This is mainly observed in geographically, culturally, or religiously isolated populations and in countries with high rates of consanguinity and endogamy that undergo rapid expansion from a limited number of ancestors. Consequently, some alleles become more frequent which explain the high frequency of some founder mutations in these populations. The founder effect may, therefore, influence mutation prevalence and gene penetrance. Since cancer risk is a function of mutation prevalence and penetrance that seems to vary by ethnicity, investigating the prevalence, the frequency, and the penetrance of novel <em>BRCA</em> mutation in different populations will bring new insights on cancer risk and etiology.</p>
<p>In Tunisia, previous studies on <em>BRCA</em> genes have focused only on breast cancer patients. In some studies, the genetic investigation concerned all the coding regions of <em>BRCA1</em> and/or <em>BRCA2</em> genes and in others only hotspot exons have been investigated. These reports have revealed a total of only 18 distinct mutations of which 12 are localized within <em>BRCA1</em> gene including 2 large rearrangements encompassing exons 5 and 20. Among the identified mutations c.211dupA, c.5266dupC in <em>BRCA1</em> and c.1310_1313delAAGA in <em>BRCA2</em> were the most recurrent mutations encountered among the hereditary breast cancer cases (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>, <a href="#B15" class="usa-link" aria-describedby="B15">15</a>–<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). Despite these efforts, the mutational spectrum of <em>BRCA1/2</em> genes is still not well established. The main goal of the present study was to identify additional novel <em>BRCA</em> mutations and to investigate the contribution of these mutations to the missing heredity of breast and ovarian cancers. We also aimed to compare breast cancer clinicopathological characteristics in BRCA+ vs <em>BRCA</em>- Tunisian breast cancer cases.</p></section><section id="s2"><h2 class="pmc_sec_title">Materials And Methods</h2>
<section id="s2_1"><h3 class="pmc_sec_title">Patients</h3>
<p>A total of 354 breast and ovarian cancer patients (335 breast cancer patients and 19 ovarian cancer patients) were included in this study referred from different medical oncology departments in Tunisia including those of Abderrahman Mami Hospital, Military Hospital of Tunis, Salah Azaiez Institute of Cancer and Farhat Hachad University Hospital University of Sousse. Written informed consents were obtained from all participants. The study has been conducted according to the Declaration of Helsinki Principles and ethical approval was obtained from the biomedical ethics committee of Institut Pasteur de Tunis (2017/16/E/Hôpital A-M). Clinico-pathological characteristics and follow-up data were collected from patients’ medical records. Probands were selected based on the following selection criteria (1): Presence of at least 3 related first or second-degree breast cancer cases at any age (2), Young cancer patients aged less than 35 years (3), Presence of at least two cases of breast or ovarian cancer, regardless of age, and at least one case of pancreatic cancer or prostate cancer in a related first- or second-degree patient (4), one case with triple negative breast cancer (TNBC) at an age ≤40 years (5), one breast cancer and one ovarian cancer cases diagnosed at first or second degree relatives at any age. A study flowchart is illustrated in <a href="#f1" class="usa-link"><strong>Figure 1</strong></a>.</p>
<figure class="fig xbox font-sm" id="f1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8417726_fonc-11-674965-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc1/8417726/2b07c3c150a7/fonc-11-674965-g001.jpg" loading="lazy" height="446" width="708" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Study flowchart.</p></figcaption></figure></section><section id="s2_2"><h3 class="pmc_sec_title">DNA Isolation</h3>
<p>Total genomic DNA was isolated from peripheral blood using DNeasy blood DNA extraction Kit (Qiagen) according to the manufacturer’s instructions. DNA purity and concentration were measured using a NanoDrop™ spectrophotometer.</p></section><section id="s2_3"><h3 class="pmc_sec_title">Screening for Recurrent Mutations in <em>BRCA1</em> and <em>BRCA2</em> Genes Using Sanger Sequencing</h3>
<p>Before performing Next Generation Sequencing (NGS) analysis, the studied cohort was screened for at least one of the recurrent <em>BRCA1/2</em> mutations previously reported in the Tunisian population, namely exon5-c.211dupA (rs397508938), exon11-c.798_799delTT (rs80357724), exon11-c.2551delG (rs397508977), exon11-c.3331_3334delCAAG (rs80357701) and exon20-c.5266dupC (rs80357906) of the <em>BRCA1</em> gene and exon10-c.1310_1313 delAAGA (rs80359277), exon16-c.7654dupA (rs879255463) in <em>BRCA2</em> gene respectively. The reference sequences used were <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a> for <em>BRCA1</em> and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a> for <em>BRCA2</em>.</p>
<p>PCR reactions were performed on genomic DNA (gDNA), following standard protocols. Sanger sequencing has been performed using an automated sequencer (ABI 3500; Applied Biosystems, Foster City, CA) and a cycle sequencing reaction kit (Bigdye Terminator v3.1 kit, Applied Biosystems). The data were analyzed using BioEdit software version 7.2.5.</p>
<p>Sanger sequencing technique was then used to validate the identified mutations resulting from NGS.</p>
<p>NGS was performed on 75 breast and ovarian cancer cases. Targeted <em>BRCA1/2</em> sequencing and whole exome sequencing were performed on 60 and 15 patients respectively.</p></section><section id="s2_4"><h3 class="pmc_sec_title">Targeted Gene Sequencing</h3>
<p>Targeted gene sequencing was performed on <em>BRCA1/2</em> for 60 breast and ovarian cancer patients with strong family history. All targeted coding exons and exon–intron boundaries of <em>BRCA1/2</em> genes were amplified with 253 pooled primer pairs. After the targeted amplification and construction of a library through QIAGEN Library Kit v2.0, the libraries were pooled prior to emulsion PCR and bead enrichment steps that were carried out using an automated protocol on the GeneRead QIAcube (QIAGEN, Hilden, Germany) using the GeneRead Clonal Amp Q Kit (QIAGEN, Hilden, Germany), according to the manufacturer’s protocol. Following bead enrichment, the pooled libraries were sequenced using the GeneReader platform (QIAGEN, Hilden, Germany).</p></section><section id="s2_5"><h3 class="pmc_sec_title">Whole Exome Sequencing</h3>
<p>WES was performed for 15 breast cancer Tunisian patients. Samples were prepared according to Agilent’s SureSelect Protocol Version 1.2 and enrichment was carried out according to Agilent SureSelect protocols. Enriched samples were sequenced on the Illumina HiSeq2000 platform using TruSeq v3 chemistry with paired-end (2 × 100). Exome DNA sequences were mapped to their location in the build of the human genome (hg19/b37) using the Burrows–Wheeler Aligner (BWA) package. The subsequent SAM files were converted to BAM files using Samtools. Duplicate reads were removed using Picard. GATK was then used to recalibrate the base quality scores as well as for SNP and short INDEL calling. Annotation and prioritization of potential disease-causing variants were performed using VarAFT (Variant Annotation and Filtering Tool) (<a href="http://varaft.eu" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://varaf t.eu</a>). To annotate variants, VarAFT uses ANNOVAR, a command line tool. INDELs and SNPs annotated were filtered according to several criteria (1): considering breast cancer as autosomal dominant disease and removing variants that were found in a homozygous state (2), variants identified as intronic, intergenic, and non-coding or synonymous were discarded (3), assuming that causal variants are rare, we removed all variants with an allele frequency &gt; 1% either in ExAC (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>), 1000 genomes (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>) or ESP6500 (<a href="http://evs.gs.washington.edu/EVS/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://evs.gs.washington.edu/EVS/</a>) (4), Using different <em>in silico</em> prediction tools, the functional impact of all identified variants has been assessed. Based on this assessment, Benign and tolerated variants were removed. Finally, significant candidate variants were obtained after filtering against their phenotypic relevance.</p></section><section id="s2_6"><h3 class="pmc_sec_title">Clinico-Pathological Features of <em>BRCA1</em> and <em>BRCA2</em> Carriers</h3>
<p>Clinical and pathological features of <em>BRCA</em>+ vs <em>BRCA</em>- patients as well as <em>BRCA1</em> vs <em>BRCA2</em> carriers were compared and evaluated. Statistical analysis was performed using SPSS software (version 23). Quantitative variables with normal distribution were analyzed by Student’s t test. Comparison of qualitative data was performed using Chi-square test. Fisher’s exact test was used for the study of small sample size. Correlation is considered statistically significant between two variables if the <em>P</em> value is less than or equal to 0.05.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3_1"><h3 class="pmc_sec_title">Epidemiological and Clinico-Pathological Features of Investigated Breast and Ovarian Cancer Patients</h3>
<p>A family history of breast and ovarian cancer was present in 35.24% and 11.14% of patients respectively. In addition, 2.68% of patients presented both breast and ovarian cancers. Consanguineous families represent 35.31% of the studied patients. Mean age at menarche was 12.81 years. Mean age at first pregnancy was 26.62 years. Oral contraception was reported by 47.31% of patients, 25.99% of patients have never breastfed and 31.85% were premenopausal.</p>
<p>The mean age at diagnosis of breast cancer was 43.10 years and 31.94% of patients were ≤35 years. Among investigated patients1.49% were male breast cancer (MBC) cases. Inflammatory breast cancer (IBC) (T4d) was seen in 8.65% of patients. Invasive ductal carcinoma (IDC) was the most frequent (90.04%) while infiltrating lobular carcinoma (ILC) was observed in only 3.94% of cases. Scarff-Bloom-Richardson (SBR) grade III was the most common (47.71%). Mean Tumor size was 33.62mm. Patients with positive lymph node disease represented 53.37% of our cohort, 88.67% of patients had Ki-67&gt;14%. Luminal B tumors were the most common (56.88%) followed by triple negative breast cancer (TNBC) (23.85%), Her2+ (11.93%) and luminal A (7.34%). Distant metastases were observed in 26.34% of patients.</p>
<p>For ovarian cancer cases, the mean age at diagnosis was 52.62 years and the majority with serous ovarian carcinoma.</p></section><section id="s3_2"><h3 class="pmc_sec_title">Genetic Analysis</h3>
<p>Genetic analysis results showed that 36 out of 354 tested breast and ovarian cancer patients were <em>BRCA1/2</em> mutation carriers (31 breast cancer cases and 5 ovarian cancer patients), including 21 patients with <em>BRCA1</em> mutation and 15 patients carrying <em>BRCA2</em> mutation. A total of 16 mutations have been identified including 11 short indels, 4 single nucleotide variations (3 nonsense &amp; 1 splicing) and 1 large rearrangement.</p></section><section id="s3_3"><h3 class="pmc_sec_title">Identified <em>BRCA1/2</em> Pathogenic Mutations in Breast Cancer Cases</h3>
<p>Within the studied breast cancer cohort, 13 pathogenic mutations have been identified: 8 in <em>BRCA1</em> and 5 in <em>BRCA2</em> genes. Among the identified mutations, 9 are described for the first time in Tunisian population (6 in <em>BRCA1</em> and 3 in <em>BRCA2</em>) <strong>(</strong><a href="#T1" class="usa-link"><strong>Table 1</strong></a><strong>)</strong>.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Mutations in the <em>BRCA1/2</em> genes identified in breast cancer and ovarian cancer patients by Sanger and next generation sequencing technologies.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Gene</th>
<th valign="top" align="center" rowspan="1" colspan="1">Exon</th>
<th valign="top" align="center" rowspan="1" colspan="1">Coding change</th>
<th valign="top" align="center" rowspan="1" colspan="1">Protein variation</th>
<th valign="top" align="center" rowspan="1" colspan="1">dbSNP rs ID</th>
<th valign="top" align="center" rowspan="1" colspan="1">Number of families carrying mutations</th>
<th valign="top" align="center" rowspan="1" colspan="1">Number of patients carrying mutations</th>
<th valign="top" align="center" rowspan="1" colspan="1">Screening method</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="10" align="left" colspan="1">
<strong><em>BRCA1</em></strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">2</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.19_47del</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Arg7fs*24</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80359871</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">5</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.211dupA</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Arg71fs*10</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs397508938</td>
<td valign="top" align="center" rowspan="1" colspan="1">5</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Sanger sequencing</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.668dupA</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Ala224Glyfs*4</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80357537</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.915T&gt;A</td>
<td valign="top" align="center" rowspan="1" colspan="1">Cys305*</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (OC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Sanger Sequencing</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.1612C&gt;T</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Gln538*</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80356893</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (2 BC, 2 OC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.2418dupA</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Ala807Serfs*3</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs886040036</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.2433delC</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Lys812fs*3</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80357524</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">11</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.3049G&gt;T</td>
<td valign="top" align="center" rowspan="1" colspan="1">Glu1017*</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80357004</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (OC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">17</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.5030_5033delCTAA</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Thr1677fs*2</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80357580</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">20</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.5266dupC</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Gln1756Profs*74</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80357906</td>
<td valign="top" align="center" rowspan="1" colspan="1">2</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Sanger sequencing</td>
</tr>
<tr>
<td valign="top" rowspan="6" align="left" colspan="1">
<br>
<strong><em>BRCA2</em></strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.249delG</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Glu83Aspfs</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (OC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">8</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.632-1G&gt;A</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs81002820</td>
<td valign="top" align="center" rowspan="1" colspan="1">5</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.1310_1313delAAGA</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Lys437fs*22</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80359277</td>
<td valign="top" align="center" rowspan="1" colspan="1">9</td>
<td valign="top" align="center" rowspan="1" colspan="1">10 (9 BC, 1 MBC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS/Sanger sequencing</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.1389_1390delAG</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Val464fs*3</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs80359283</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (MBC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">16</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.7654dupA</td>
<td valign="top" align="center" rowspan="1" colspan="1">p.Ile2552Asnfs*2</td>
<td valign="top" align="center" rowspan="1" colspan="1">rs879255463</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Sanger sequencing</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1">1-16</td>
<td valign="top" align="center" rowspan="1" colspan="1">c.-227-?_7805+?</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (BC)</td>
<td valign="top" align="left" rowspan="1" colspan="1">NGS</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn5"><p>BC, breast cancer; MBC, Male Breast Cancer; OC, ovarian cancer; NGS, Next Generation Sequencing.</p></div>
<div class="fn" id="fn6"><p>The * symbol design the codon stop/frameshift mutation (fs).</p></div>
</div></section><p>Considering the <em>BRCA1</em> gene, 6 patients belonging to 5 unrelated families were carriers of the recurrent c.211dupA mutation. Three patients belonging to 2 unrelated families were positive for c.5266dupC mutation. The missense c.1612C&gt;T mutation has been identified in 2 related patients. c.19_47del, c.668dupA, c.2418dupA and c.5030_5033delCTAA mutations have been identified each in one patient. c.2433delC has been identified among 2 related patients. Except c.211dupA and c.5266dupC mutations, all remaining <em>BRCA1</em> mutations are reported for the first time in the Tunisian population.</p>
<p>In the <em>BRCA2</em> gene, 3 frameshift mutations as well as 1 splicing and 1 large rearrangement mutation were detected. Our results revealed 6 patients belonging to 5 unrelated families that are double heterozygous for <em>BRCA2</em> gene. Indeed, these families were carrying two mutations classified as pathogenic in the ClinVar database namely c.632-1G&gt;A and c.1310_1313delAAGA. Four additional patients carrying only the c.1310_1313delAAGA mutation have been identified including one male breast cancer. The c.7654dupA mutation was identified in 2 related patients with a strong family history of hereditary breast and ovarian cancer. The c.1389_1390delAG mutation has been identified in 1 additional male breast cancer case. Similarly, a large rearrangement mutation of <em>BRCA2</em> gene (Del exons 1-16) has been identified in one patient. Among the identified <em>BRCA2</em> mutations, <em>BRCA2</em>-Del exons 1-16 mutation is novel and was not described in public databases. c.632-1G&gt;A and c.1389_1390delAG are described for the first time in the Tunisian population.</p></section><section id="s3_4"><h3 class="pmc_sec_title">
<em>BRCA1/2</em> Pathogenic Mutations Identified in Ovarian Cancer Cases</h3>
<p>A total of 19 ovarian cancer patients were screened for <em>BRCA</em> pathogenic mutations using Sanger and/or NGS. Four distinct deleterious mutations were identified: 3 mutations in <em>BRCA1</em> gene (c.915T&gt;A, c.1612C&gt;T and c.3049G&gt;T) and one <em>BRCA2</em> mutation (c.249delG).</p>
<p><em>BRCA1</em>-c.915T&gt;A and <em>BRCA2</em>-c.249delG mutations are novel and not described in public databases. The other identified mutations are described for the first time in the Tunisian population. c.1612C&gt;T mutation was identified among 2 patients. This same mutation was also identified in 2 related breast cancer patients. Screening for additional carriers of the identified mutations, based on their geographic origin, was performed using Sanger sequencing. Consequently, the geographic origin of the identified <em>BRCA1/2</em> mutations has been clearly established (<a href="#f2" class="usa-link"><strong>Figure 2</strong></a>). We have also illustrated the distribution of <em>BRCA</em> mutations identified in hereditary breast and ovarian cases on <em>BRCA1</em> and <em>BRCA2</em> genes (<a href="#f3" class="usa-link"><strong>Figure 3</strong></a>). Breast cancer cluster regions (BCCRs) and ovarian cancer cluster regions (OCCRs) were assigned in <a href="#f3" class="usa-link"><strong>Figure 3</strong></a> according to the study of Rebbeck et al., 2015 (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>). Among <em>BRCA</em> mutations identified in breast cancer patients, <em>BRCA1_c</em>.211dupA, <em>BRCA1</em>_c.5266dupC, <em>BRCA2</em>_c.-227-?_7805+?, <em>BRCA2</em>_1310_1313delAAGA, <em>BRCA2</em>_c.1389_1390delAG and <em>BRCA2</em>_c.7654dupA occurred in BCCRs. Considering <em>BRCA</em> mutations identified in ovarian cancer patients <em>BRCA1</em>_c.1612C&gt;T and <em>BRCA1</em>_3049G&gt;T arose in OCCRs.</p>
<figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8417726_fonc-11-674965-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc1/8417726/94dbe21cbaac/fonc-11-674965-g002.jpg" loading="lazy" height="987" width="767" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Geographical distribution of the identified <em>BRCA1</em> and <em>BRCA2</em> mutations.</p></figcaption></figure><figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8417726_fonc-11-674965-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc1/8417726/07d7988ae324/fonc-11-674965-g003.jpg" loading="lazy" height="396" width="669" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of <em>BRCA1</em> and <em>BRCA2</em> mutations identified in hereditary breast and ovarian cancer cases. The Length of mutation indicator reflects the number of observed carriers. The diagrams linearly represent BRCA1/2 protein domains (x-axis). BRCA1 domains: Zinc/Ring finger (green); BRCT_assoc: serine-rich domain associated with BRCT (red); Ethylene insensitive 3 (blue); BRCA1 C terminus domain (yellow). BRCA2 domains: BRC repeats (green); BRCA-2_helical (red); oligonucleotide/oligosaccharide-binding, domain 1 (blue); tower domain (yellow) and oligonucleotide/oligosaccharide-binding, domain 3 (purple). Black mutation indicators depict truncating mutations and purple indicators represent the other types of mutations (splicing, LR). Cluster regions (breast cancer cluster regions (BCCRs) (orange) and ovarian cancer cluster regions (OCCRs) (yellow) were assigned according to the study of Rebbeck et al. (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>).</p></figcaption></figure></section><section id="s3_5"><h3 class="pmc_sec_title">Polymorphisms and Variant of Unknown Significance Identified in <em>BRCA1</em> and <em>BRCA2</em> Genes</h3>
<p>In addition to the pathogenic mutations that have been identified in <em>BRCA</em> genes, several SNPs and variants of unknown significance (VUS) have been observed <strong>(</strong><a href="#SM1" class="usa-link"><strong>Supplementary Table 1</strong></a><strong>)</strong>. Among the 101 identified variants, 45.54% were coding, 50.49% were intronic and 3.96% were localized within regulatory regions. The majority of variations were classified as benign or likely benign in the ClinVar database (91.08%) and five intronic variations were not reported. One patient carried a VUS rs397507308 in <em>BRCA2</em> and 3 other patients carried 2 intronic variations (rs276174878 and rs276174816) that have conflicting interpretations of pathogenicity. Another patient diagnosed with early onset bilateral breast cancer had an in-frame variant with conflicting interpretations of pathogenicity rs80358343 (c.5017_5019delCAC) in the <em>BRCA1</em> gene.</p></section><section id="s3_6"><h3 class="pmc_sec_title">Clinico-Pathological Features of <em>BRCA</em> Carriers Among Breast Cancer Cohort</h3>
<p>Clinico-pathological characteristics of breast cancer cases carrying <em>BRCA1</em> and <em>BRCA2</em> mutations are described in <a href="#T2" class="usa-link"><strong>Tables 2</strong></a>, <a href="#T3" class="usa-link"><strong>3</strong></a> respectively. We investigated these clinico-pathological features in <em>BRCA1/2</em> mutation carriers vs <em>BRCA negative patients</em> (<a href="#T4" class="usa-link"><strong>Table 4</strong></a>) and between <em>BRCA1</em> and <em>BRCA2</em> mutation carriers (<a href="#T5" class="usa-link"><strong>Table 5</strong></a>), as well.</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Clinicopathological features of <em>BRCA1</em> carriers.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Mutation</th>
<th valign="top" align="center" rowspan="1" colspan="1">Carrier ID</th>
<th valign="top" align="center" rowspan="1" colspan="1">Pathology</th>
<th valign="top" align="center" rowspan="1" colspan="1">Age at diagnosis (years)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Family History BC/OC</th>
<th valign="top" align="center" rowspan="1" colspan="1">Family history of other cancers</th>
<th valign="top" align="center" rowspan="1" colspan="1">Histological subtype</th>
<th valign="top" align="center" rowspan="1" colspan="1">SBR grade</th>
<th valign="top" align="center" rowspan="1" colspan="1">ER status</th>
<th valign="top" align="center" rowspan="1" colspan="1">PR status</th>
<th valign="top" align="center" rowspan="1" colspan="1">HER2 status</th>
<th valign="top" align="center" rowspan="1" colspan="1">Ki67- index (%)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Nodal status</th>
<th valign="top" align="center" rowspan="1" colspan="1">Tumor size (mm)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Follow-up</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>c.19_47del</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC320-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">35</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 gastric, 2 lung, 1 esophageal</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER+</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR-</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2+</td>
<td valign="top" align="center" rowspan="1" colspan="1">70%</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">25</td>
<td valign="top" align="left" rowspan="1" colspan="1">Bone and lung metastases at 37 years old.</td>
</tr>
<tr>
<td valign="middle" rowspan="6" align="left" colspan="1">
<strong>c.211dupA</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC9-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/OC/CBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">42</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC/OC<br>1 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Cervical cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">OC at 57 years old<br>CBC at 63 years old<br>Died at 67 years old</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC49-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/CBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">29</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" rowspan="2" align="left" colspan="1">Leukemia, Prostate, Colon, Gynecological cancer, Larynx</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER-</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR-</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">35</td>
<td valign="top" align="left" rowspan="1" colspan="1">Spontaneous pregnancy 6 months after the end of CT CBC at 32 years old (ER+, PR-, HER2-)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC49-2</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">37</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER +</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR +</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">40</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">Patient in complete<br>remission, under regular surveillance.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC199-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">58</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC<br>1 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Endometrium</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">2</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">40</td>
<td valign="top" align="left" rowspan="1" colspan="1">Bone and Lung metastases at initial diagnosis<br>Disease progression, cerebral metastases<br>Died at 59 years old</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC204</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC<br>2 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Thyroid</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">N-</td>
<td valign="top" align="center" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">OC at 41 years old.<br>Patient in complete remission, under regular surveillance.</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">PEC50-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">38</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 Lung,<br>1 Pancreatic</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR-</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>c.668dupA</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC420</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">64</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Colorectal,1 tongue cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left" colspan="1">
<strong>c.1612C&gt;T</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC276-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">25</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 BC<br>1 BOC<br>1 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Lung,<br>1 head and neck</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR-</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">22</td>
<td valign="top" align="left" rowspan="1" colspan="1">Disease progression, multiple metastases</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC276-3</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">ND</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC<br>1 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Lung</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">80</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Discovery of ovarian involvement during a preoperative examination for a prophylactic oophorectomy</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>c.2418dupA</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC93</td>
<td valign="top" align="left" rowspan="1" colspan="1">IBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">34</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Lung, 1 pancreatic</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Bone metastases Died at 36 years old due to disease progression</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left" colspan="1">
<strong>c.2433delC</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC178-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/CBC/Endometrial cancer</td>
<td valign="top" align="center" rowspan="1" colspan="1">42</td>
<td valign="top" rowspan="2" align="left" colspan="1">2 BC<br>1 OC</td>
<td valign="top" rowspan="2" align="left" colspan="1">2 Lung, 1 colorectal, 1 bladder</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">25</td>
<td valign="top" align="left" rowspan="1" colspan="1">CBC at 45 years old; Endometrial cancer at 55 years old with peritoneal metastases</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC178-2</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/CBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">45</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">N-</td>
<td valign="top" align="center" rowspan="1" colspan="1">13</td>
<td valign="top" align="left" rowspan="1" colspan="1">CBC at 52 years old</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>c.5030_5033delCTAA</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC70</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/OC</td>
<td valign="top" align="center" rowspan="1" colspan="1">47</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 BC<br>1 OC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Lung</td>
<td valign="top" align="left" rowspan="1" colspan="1">Polymorphic IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">65</td>
<td valign="top" align="left" rowspan="1" colspan="1">N-</td>
<td valign="top" align="center" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">Complete remission<br>Died at 58 years old</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left" colspan="1">
<strong>c.5266dupC</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC81-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC/(CBC: PABC)</td>
<td valign="top" align="center" rowspan="1" colspan="1">27</td>
<td valign="top" rowspan="2" align="left" colspan="1">4 BC</td>
<td valign="top" rowspan="2" align="left" colspan="1">1 Pancreatic<br>1 colorectal<br>cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">N-</td>
<td valign="top" align="center" rowspan="1" colspan="1">24</td>
<td valign="top" align="left" rowspan="1" colspan="1">PABC at 32 years</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC81-6</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">36</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER -</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2+</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC314</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">29</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Prostate</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="left" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER +</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR +</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="center" rowspan="1" colspan="1">40</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn7"><p>BC, breast cancer; OC, ovarian cancer; CBC, contralateral breast cancer; IDC, invasive ductal carcinoma; PABC, Pregnancy associated breast cancer; NA, non available; PR, Progesterone receptor; ER, Estrogen receptor.</p></div></div></section><section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Clinico-pathological features of <em>BRCA2</em> carriers.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Mutation</th>
<th valign="top" align="center" rowspan="1" colspan="1">Carrier ID</th>
<th valign="top" align="center" rowspan="1" colspan="1">Pathology</th>
<th valign="top" align="center" rowspan="1" colspan="1">Age at diagnosis (years)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Family History BC/OC</th>
<th valign="top" align="center" rowspan="1" colspan="1">Family history of other cancers</th>
<th valign="top" align="center" rowspan="1" colspan="1">Histological subtype</th>
<th valign="top" align="center" rowspan="1" colspan="1">SBR grade</th>
<th valign="top" align="center" rowspan="1" colspan="1">ER status</th>
<th valign="top" align="center" rowspan="1" colspan="1">PR status</th>
<th valign="top" align="center" rowspan="1" colspan="1">HER2 status</th>
<th valign="top" align="center" rowspan="1" colspan="1">Nodal status</th>
<th valign="top" align="center" rowspan="1" colspan="1">Tumor size (mm)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Ki67- index (%)</th>
<th valign="top" align="center" rowspan="1" colspan="1">Follow-up</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="9" align="left" colspan="1">
<strong>DH (c.632-1G&gt;A, c.1310_1313delAAGA</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC6-1</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">40</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Throat cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Died at 44 years old</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left" colspan="1">BC17-1</td>
<td valign="top" rowspan="2" align="left" colspan="1">BBC</td>
<td valign="top" rowspan="2" align="center" colspan="1">36</td>
<td valign="top" rowspan="2" align="left" colspan="1">9 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Gastric cancer</td>
<td valign="top" rowspan="2" align="left" colspan="1">IDC</td>
<td valign="top" rowspan="2" align="center" colspan="1">III</td>
<td valign="top" rowspan="2" align="left" colspan="1">ER+</td>
<td valign="top" rowspan="2" align="left" colspan="1">PR+</td>
<td valign="top" rowspan="2" align="left" colspan="1">NA</td>
<td valign="top" rowspan="2" align="left" colspan="1">N+</td>
<td valign="top" rowspan="2" align="center" colspan="1">25</td>
<td valign="top" rowspan="2" align="center" colspan="1">NA</td>
<td valign="top" rowspan="2" align="left" colspan="1">Esophageal Carcinoma at 48 years old.<br>Disease progression, laterocervical, bone and liver metastases.<br>Died at 50 years old</td>
</tr>
<tr><td valign="top" align="left" rowspan="1" colspan="1">1 Kidney cancer</td></tr>
<tr>
<td valign="top" rowspan="2" align="left" colspan="1">BC17-2</td>
<td valign="top" rowspan="2" align="left" colspan="1">BC (PABC)/CBC</td>
<td valign="top" rowspan="2" align="center" colspan="1">25</td>
<td valign="top" rowspan="2" align="left" colspan="1">9 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Gastric cancer</td>
<td valign="top" rowspan="2" align="left" colspan="1">IDC</td>
<td valign="top" rowspan="2" align="center" colspan="1">II</td>
<td valign="top" rowspan="2" align="left" colspan="1">ER +</td>
<td valign="top" rowspan="2" align="left" colspan="1">PR +</td>
<td valign="top" rowspan="2" align="left" colspan="1">HER2-</td>
<td valign="top" rowspan="2" align="left" colspan="1">N+</td>
<td valign="top" rowspan="2" align="center" colspan="1">55</td>
<td valign="top" rowspan="2" align="center" colspan="1">20</td>
<td valign="top" rowspan="2" align="left" colspan="1">CBC<br>Bone metastases, Unplanned pregnancy during BC treatment<br>Lung metastases at 27 years old</td>
</tr>
<tr><td valign="top" align="left" rowspan="1" colspan="1">1 Kidney cancer</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC39</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">27</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="center" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER +</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR +</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="left" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="left" rowspan="1" colspan="1">Bone and liver metastases at initial diagnosis<br>Disease progression, patient died at 35 years old</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC95</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">32</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 Colorectal cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="center" rowspan="1" colspan="1">I</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER+</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR+</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="left" rowspan="1" colspan="1">N-</td>
<td valign="top" align="center" rowspan="1" colspan="1">7</td>
<td valign="top" align="center" rowspan="1" colspan="1">50</td>
<td valign="top" align="left" rowspan="1" colspan="1">Patient in complete remission, under regular surveillance</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left" colspan="1">BC225-1</td>
<td valign="top" rowspan="2" align="left" colspan="1">BC</td>
<td valign="top" rowspan="2" align="center" colspan="1">50</td>
<td valign="top" rowspan="2" align="left" colspan="1">5 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 cerebral cancer</td>
<td valign="top" rowspan="2" align="left" colspan="1">IDC</td>
<td valign="top" rowspan="2" align="center" colspan="1">III</td>
<td valign="top" rowspan="2" align="left" colspan="1">ER+</td>
<td valign="top" rowspan="2" align="left" colspan="1">PR+</td>
<td valign="top" rowspan="2" align="left" colspan="1">HER2-</td>
<td valign="top" rowspan="2" align="left" colspan="1">N+</td>
<td valign="top" rowspan="2" align="center" colspan="1">20</td>
<td valign="top" rowspan="2" align="center" colspan="1">60</td>
<td valign="top" rowspan="2" align="left" colspan="1">Under regular surveillance</td>
</tr>
<tr><td valign="top" align="left" rowspan="1" colspan="1">2 esophageal</td></tr>
<tr>
<td valign="top" rowspan="7" align="left" colspan="1">
<strong>c.1310_1313delAAGA</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC245</td>
<td valign="top" align="left" rowspan="1" colspan="1">IBC (PABC)<br>CBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">36</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="center" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER+</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR+</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">80</td>
<td valign="top" align="left" rowspan="1" colspan="1">CBC at 37 years old</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">PEC009</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">33</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">None</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="center" rowspan="1" colspan="1">II</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER+</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR+</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">25</td>
<td valign="top" align="left" rowspan="1" colspan="1"> Under regular surveillance</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left" colspan="1">PEC0035</td>
<td valign="top" rowspan="2" align="left" colspan="1">MBC</td>
<td valign="top" rowspan="2" align="center" colspan="1">43</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 MBC</td>
<td valign="top" rowspan="2" align="left" colspan="1">None</td>
<td valign="top" rowspan="2" align="left" colspan="1">IDC</td>
<td valign="top" rowspan="2" align="center" colspan="1">III</td>
<td valign="top" rowspan="2" align="left" colspan="1">ER+</td>
<td valign="top" rowspan="2" align="left" colspan="1">PR+</td>
<td valign="top" rowspan="2" align="left" colspan="1">HER2-</td>
<td valign="top" rowspan="2" align="left" colspan="1">N+</td>
<td valign="top" rowspan="2" align="center" colspan="1">7</td>
<td valign="top" rowspan="2" align="center" colspan="1">30</td>
<td valign="top" rowspan="2" align="left" colspan="1">Under regular surveillance</td>
</tr>
<tr><td valign="top" align="left" rowspan="1" colspan="1">1 BC</td></tr>
<tr>
<td valign="top" rowspan="3" align="left" colspan="1">BC354-1</td>
<td valign="top" rowspan="3" align="left" colspan="1">BC</td>
<td valign="top" rowspan="3" align="center" colspan="1">37</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 pancreatic</td>
<td valign="top" rowspan="3" align="left" colspan="1">ILC</td>
<td valign="top" rowspan="3" align="center" colspan="1">I</td>
<td valign="top" rowspan="3" align="left" colspan="1">ER+</td>
<td valign="top" rowspan="3" align="left" colspan="1">PR+</td>
<td valign="top" rowspan="3" align="left" colspan="1">HER2-</td>
<td valign="top" rowspan="3" align="left" colspan="1">N+</td>
<td valign="top" rowspan="3" align="center" colspan="1">25</td>
<td valign="top" rowspan="3" align="center" colspan="1">15</td>
<td valign="top" rowspan="3" align="left" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1 IBC</td>
<td valign="top" rowspan="2" align="left" colspan="1">1 Lung</td>
</tr>
<tr><td valign="top" align="left" rowspan="1" colspan="1">1 MBC</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>c.1389_1390delAG</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">PEC0056</td>
<td valign="top" align="left" rowspan="1" colspan="1">MBC</td>
<td valign="top" align="center" rowspan="1" colspan="1">59</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 bladder</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="center" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER+</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR -</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">54</td>
<td valign="top" align="center" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">Under regular surveillance</td>
</tr>
<tr>
<td valign="top" rowspan="4" align="left" colspan="1">
<strong>c.7654dupA</strong>
</td>
<td valign="top" rowspan="3" align="left" colspan="1">BC231-1</td>
<td valign="top" rowspan="3" align="left" colspan="1">BC/OC</td>
<td valign="top" rowspan="3" align="center" colspan="1">47</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 BC</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 Gastric,</td>
<td valign="top" rowspan="3" align="left" colspan="1">IDC</td>
<td valign="top" rowspan="3" align="center" colspan="1">III</td>
<td valign="top" rowspan="3" align="left" colspan="1">ER+</td>
<td valign="top" rowspan="3" align="left" colspan="1">PR +</td>
<td valign="top" rowspan="3" align="left" colspan="1">HER2-</td>
<td valign="top" rowspan="3" align="left" colspan="1">N-</td>
<td valign="top" rowspan="3" align="center" colspan="1">55</td>
<td valign="top" rowspan="3" align="center" colspan="1">NA</td>
<td valign="top" rowspan="3" align="left" colspan="1">OC at 51 years old</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left" colspan="1">1 BOC</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 prostate,</td>
</tr>
<tr><td valign="top" rowspan="2" align="left" colspan="1">1 hepatic cancers</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC231-2</td>
<td valign="top" align="left" rowspan="1" colspan="1">BC</td>
<td valign="top" align="center" rowspan="1" colspan="1">34</td>
<td valign="top" align="left" rowspan="1" colspan="1">IDC</td>
<td valign="top" align="center" rowspan="1" colspan="1">III</td>
<td valign="top" align="left" rowspan="1" colspan="1">ER+</td>
<td valign="top" align="left" rowspan="1" colspan="1">PR +</td>
<td valign="top" align="left" rowspan="1" colspan="1">HER2-</td>
<td valign="top" align="left" rowspan="1" colspan="1">N+</td>
<td valign="top" align="center" rowspan="1" colspan="1">16</td>
<td valign="top" align="center" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">Under regular surveillance</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left" colspan="1">
<strong>c.-227-?_7805+?</strong>
</td>
<td valign="top" rowspan="2" align="left" colspan="1">BC287</td>
<td valign="top" rowspan="2" align="left" colspan="1">IBC<br>(PABC)</td>
<td valign="top" rowspan="2" align="center" colspan="1">36</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 BC<br>1 BBC<br>1 BOC<br>1MBC/prostate cancer</td>
<td valign="top" rowspan="2" align="left" colspan="1">1 Larynx</td>
<td valign="top" rowspan="2" align="left" colspan="1">IDC</td>
<td valign="top" rowspan="2" align="center" colspan="1">III</td>
<td valign="top" rowspan="2" align="left" colspan="1">ER+</td>
<td valign="top" rowspan="2" align="left" colspan="1">PR +</td>
<td valign="top" rowspan="2" align="left" colspan="1">HER2-</td>
<td valign="top" rowspan="2" align="left" colspan="1">NA</td>
<td valign="top" rowspan="2" align="center" colspan="1">NA</td>
<td valign="top" rowspan="2" align="center" colspan="1">40</td>
<td valign="top" rowspan="2" align="left" colspan="1">Contralateral prophylactic mastectomy<br>Under regular surveillance</td>
</tr>
<tr><td valign="top" align="left" rowspan="1" colspan="1">1 IBC</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn8"><p>BC, breast cancer; OC, ovarian cancer; CBC, contralateral breast cancer; IDC, invasive ductal carcinoma; PABC, Pregnancy associated breast cancer; NA, non available; PR, Progesterone receptor; ER, Estrogen receptor.</p></div></div></section><section class="tw xbox font-sm" id="T4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Epidemiological and clinico-pathological characteristics of patients carrying or not <em>BRCA1/2</em> mutations.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Variables</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>BRCA1/2+</em>N=31</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>BRCAx</em>N=52</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Mean age at diagnosis (years)</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">38.37</td>
<td valign="top" align="center" rowspan="1" colspan="1">43.14</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.049</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Early age at onset (≤35 years)</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/30 (40.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11/50 (22%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.085</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">18/30 (60.0%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">39/50 (78%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Family history of breast cancer</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">28/31 (90.32%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">42/52 (80.77%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.353</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/31 (9.68%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/52 (19.23%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Family history of ovarian cancer</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">11/31 (35.48%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/51 (9.80%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.004</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">20/31 (64.52%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">46/51 (90.20%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Personal history of cancers</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/31 (16.13%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/51 (7.84%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.288</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">26/31 (83.87%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">47/51 (92.16%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Consanguinity</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">7/30 (23.23%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">13/50 (26%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.790</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">23/30 (76.77%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">37/50 (74%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Histological type</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>IDC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">28/29 (96.55%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">26/30 (86.67%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.353</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Other</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/29 (3.45%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/30 (13.33%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>SBR Grade</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Grade I</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/26 (7.69%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/28 (17.86%)</td>
<td valign="top" rowspan="3" align="center" colspan="1">0.027</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Grade II</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">7/26 (26.92%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">15/28 (53.57%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Grade III</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">17/26 (65.38%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/28 (28.57%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Mean tumor size (mm)</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">27.15</td>
<td valign="top" align="center" rowspan="1" colspan="1">36.15</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.201</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>T stage</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>T1-T2</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/15 (60.00%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/14 (64.29%)</td>
<td valign="top" rowspan="3" align="center" colspan="1">0.750</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>T3</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/15 (6.67%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/14 (14.29%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>T4</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/15 (33.33%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/14 (21.42%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Nodes involvement</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>N+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">15/21 (71.43%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">14/26 (53.85%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.218</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>N-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">6/21 (28.57%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/26 (46.15%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Mean Ki-67 (%)</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">38.79</td>
<td valign="top" align="center" rowspan="1" colspan="1">34.95</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.598</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Ki-67 index status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Ki-67 ≤14%</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/19 (5%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/21 (9.52%)</td>
<td valign="top" rowspan="2" align="center" colspan="1"> 1</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Ki-67&gt;14%</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">18/19 (95%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">19/21 (90.48%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Molecular subtypes</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Luminal A</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/23 (4.35%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/29 (6.90%)</td>
<td valign="top" rowspan="4" align="center" colspan="1">0.926</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Luminal B</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/23 (52.17%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">14/29 (48.28%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Her2+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/23 (4.35%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/29 (10.34%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>TNBC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/23 (39.13%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/29 (34.48%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>ER receptor status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>RE+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">16/26 (61.54%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">23/37 (62.16%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.960</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>RE-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/26 (385.46%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">14/37 (37.84%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>PR receptor status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>PR+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">14/26 (53.85%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">22/37 (59.46%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.658</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>PR-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/26 (46.15%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">15/37 (40.54%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>HER2 receptor status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>HER2+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/25 (8.00%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/33 (24.24%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.163</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>HER2-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">23/25 (92.00%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">25/33 (75.76%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>TNBC</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>TNBC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/23 (39.13%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/29 (34.48%)</td>
<td valign="top" rowspan="2" align="center" colspan="1"> 0.778</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Non-TNBC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">14/23 (60.87%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">19/29 (65.52%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Metastatic status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>M0</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">18/24 (75.00%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">22/32 (68.75%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.608</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>M1</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">6/24 (25.00%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/32 (31.25%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="T5"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>Epidemiological and clinico-pathological characteristics of patients carrying <em>BRCA1</em> and <em>BRCA2</em> mutations.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Variables</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>BRCA1+</em>N=17</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>BRCA2+</em>N=14</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Mean age at diagnosis (years)</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">38.50</td>
<td valign="top" align="center" rowspan="1" colspan="1">38.21</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.939</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Early age at onset (≤35 years)</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">7/16 (43.75%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/14 (35.71%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.654</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/16 (56.25%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/14 (64.29%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Family history of breast cancer</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">16/17 (94.12%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/14 (85.71%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.576</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/17 (5.88%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/14 (14.29%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Family history of ovarian cancer</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/17 (47.06%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/14 (21.43%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.258</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/17 (52.94%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11/14 (78.57%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Personal history of cancers</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/17 (23.53%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/14 (5.88%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.344</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">13/17 (76.47%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">13/14 (94.12%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Consanguinity</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Yes</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/17 (11.76%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5/13 (38.46%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.190</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>No</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">15/17 (88.24%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/13(61.54%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Histological type</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>IDC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">15/15 (100%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">13/14 (92.86%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.483</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Other</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/15</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/14 (7.14%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>SBR grade</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Grade I</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/13</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/13 (15.38%)</td>
<td valign="top" rowspan="3" align="center" colspan="1">0.673</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Grade II</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/13 (30.77%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/13 (23.08%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Grade III</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/13 (69.23%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/13 (61.54%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Mean tumor size (mm)</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">25.36</td>
<td valign="top" align="center" rowspan="1" colspan="1">29.33</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.555</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>T stage</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>T1-T2</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/5 (60%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6/10 (60%)</td>
<td valign="top" rowspan="3" align="center" colspan="1">0.045</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>T3</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/5 (20%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/10</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>T4</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/5 (20%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/10 (40%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Nodes involvement</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>N+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">6/10 (60%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/11 (81.82%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.361</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>N-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/10 (40%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/11 (18.18%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Mean Ki-67 (%)</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">40.78</td>
<td valign="top" align="center" rowspan="1" colspan="1">37.00</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.727</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Ki-67 index status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Ki-67 ≤14%</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/9 (11.11%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/10</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.474</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Ki-67&gt;14%</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/9 (88.89%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/10 (100%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Molecular subtypes</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Luminal A</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/13 (7.69%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/10</td>
<td valign="top" rowspan="4" align="center" colspan="1">0.000078</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Luminal B</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/13 (15.39%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/10 (100%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Her2+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/13 (7.69%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/10</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>TNBC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/13 (69.23%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/10</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>ER receptor status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>RE+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/13 (23.08%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">13/13 (100%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.000056</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>RE-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/13 (76.92%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/15</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>PR receptor status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>PR+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/13 (15.38%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/13 (92.31%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.000084</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>PR-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">11/13 (84.62%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1/13 (7.69%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>HER2 receptor status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>HER2+</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/13 (15.38%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/12</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.480</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>HER2-</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">11/13 (84.62%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12/12 (100%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>TNBC</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>TNBC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">9/13 (69.23%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0/10</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.002</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>Non-TNBC</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">4/13 (30.77%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/10 (100%)</td>
</tr>
<tr><td valign="top" colspan="4" align="left" rowspan="1">
<strong>Metastatic status</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>M0</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">8/11 (72.73%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10/12 (83.33%)</td>
<td valign="top" rowspan="2" align="center" colspan="1">0.640</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> <strong>M1</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">3/11 (27.27%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2/12 (16.67%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s3_7"><h3 class="pmc_sec_title">
BRCA+ vs BRCA-
</h3>
<p>Family history of ovarian cancer was significantly associated with <em>BRCA</em> positive status (p=0.004). Regarding the mean age at diagnosis <em>BRCA</em> carriers seem to be younger than <em>BRCA-</em> patients (38.37 vs 43.14) (p= 0.049). However, no significant difference has been observed between both groups regarding family history of breast cancer, personal history of cancer and consanguinity. Similarly, no significant differences have been observed between the 2 groups in histological subtype, nodal involvement, tumor stage, hormonal receptors status, HER2 status, molecular subtypes, Ki-67 index, and metastases <strong>(</strong><a href="#T4" class="usa-link"><strong>Table 4</strong></a><strong>)</strong>. Nevertheless, SBR grade III was found in 65.38% of patients with <em>BRCA1/2</em> mutations against a frequency of 28.57% among non-carriers, this difference appears to be statistically significant (p= 0.027).</p></section><section id="s3_8"><h3 class="pmc_sec_title">
BRCA1 vs BRCA2
</h3>
<p>Association between clinico-pathological features and <em>BRCA</em> status (<em>BRCA1+, BRCA2+</em> and <em>BRCAx</em>) was shown in <a href="#f4" class="usa-link"><strong>Figures 4</strong></a>, <a href="#f5" class="usa-link"><strong>5</strong></a>. Our results showed that there were no significant differences between <em>BRCA1</em> and <em>BRCA2</em> mutated groups regarding the mean age at diagnosis, the family history of personal cancers, of breast cancer and ovarian cancer (<a href="#T5" class="usa-link"><strong>Table 5</strong></a>).</p>
<figure class="fig xbox font-sm" id="f4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8417726_fonc-11-674965-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc1/8417726/1a0e67f728ce/fonc-11-674965-g004.jpg" loading="lazy" height="354" width="682" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/f4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of clinico-pathological features of breast cancer in <em>BRCA1</em>+ and <em>BRCA2</em>+ patients.</p></figcaption></figure><figure class="fig xbox font-sm" id="f5"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8417726_fonc-11-674965-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc1/8417726/f2cfdd49a367/fonc-11-674965-g005.jpg" loading="lazy" height="347" width="689" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/f5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of clinico-pathological features of breast cancer in <em>BRCA</em>+ and <em>BRCAx</em> patients.</p></figcaption></figure><p>Pathology showed that the infiltrating ductal carcinoma was the most common histological type in both groups (100% and 92.86%). HER2 status, lymph node involvement, SBR grade, tumor size, Ki-67 index and metastatic status showed no statistically significant difference between both studied groups. However, <em>BRCA1</em> carriers were more likely to have triple negative breast cancer (p=0.002) and <em>BRCA2</em> carriers were more likely to have luminal B breast cancer tumors (p=0.000078). In addition, positive estrogen receptor (ER) status and positive progesterone receptor (PR) status studied separately were both associated with <em>BRCA2</em> mutated tumors (p=0.000056 and p=0.000084), respectively.</p></section><section id="s3_9"><h3 class="pmc_sec_title">Follow Up of <em>BRCA1</em> and <em>BRCA2</em> Carriers</h3>
<p>Among <em>BRCA</em> carriers, contralateral breast cancer and ovarian cancer co-occurrence were observed respectively in 22.58% and 16.12% of cases. One patient diagnosed with early onset breast cancer has undergone a contralateral prophylactic mastectomy and is currently under regular surveillance. Both contralateral breast cancer and ovarian cancer occurrence were more frequent in <em>BRCA1</em> than <em>BRCA2</em> carriers. Also, 22.58% of the carriers have developed distant metastases and 5 cases died due to disease progression.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Detection of mutations in hereditary breast and ovarian cancer related <em>BRCA1</em> and <em>BRCA2</em> genes is an effective method of cancer prevention, early detection, and treatment. Mutations in the highly penetrant <em>BRCA</em> genes explain around a quarter of these cases (<a href="#B27" class="usa-link" aria-describedby="B27">27</a>). The frequency of germline mutations identified on both genes varies depending on the geographic and ethnic distributions. In some populations, a wide spectrum of different mutations is present, whereas in other groups specific recurrent <em>BRCA</em> mutations have been reported that may be due to the founder mutation effect (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>–<a href="#B32" class="usa-link" aria-describedby="B32">32</a>).</p>
<p>Our previous studies, investigating breast cancer loci and Nucleotide Excision Repair pathway, have shown that the Tunisian population is an admixed and intermediate population between Sub-Saharan Africans and Europeans (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>, <a href="#B34" class="usa-link" aria-describedby="B34">34</a>). This genetic diversity reflects the inter-ethnic variability in the frequency distribution of the studied polymorphisms. Indeed, allele frequencies of several variants were found to be statistically different between Tunisian and other populations including rs2046210 and rs941764 that site in breast cancer susceptibility loci (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>). These findings are in favor of the genetic heterogeneity to breast cancer predisposition in the Tunisian population. So far, only 18 deleterious <em>BRCA</em> mutations have been reported. In the current study, 16 <em>BRCA</em> mutations, including 11 novel variations, have been identified in a cohort of 354 Tunisian breast and ovarian cancer patients. For breast cancer cases, high fractions of young patients (31.94%), cases with family history of breast cancer (35.24%), Triple negative breast cancer (24.31%) and high tumor grade (47.41%) have been observed. As reported in previous studies, the high fractions of early onset, triple negative cases and also the presence of family history of breast cancer may be associated with germline <em>BRCA</em> mutations (<a href="#B35" class="usa-link" aria-describedby="B35">35</a>, <a href="#B36" class="usa-link" aria-describedby="B36">36</a>). Indeed, it is now well documented that breast cancer patients in North Africa are almost 10 years younger than patients from western countries (<a href="#B37" class="usa-link" aria-describedby="B37">37</a>). In Tunisia, around 11% of breast cancer cases are under 35 years old (<a href="#B38" class="usa-link" aria-describedby="B38">38</a>). In fact, at a young age, the human organism usually functions as well as it ever will. However, interactions between some genetic and environmental factors (GxE) may cause a physiological decline of some organism systems leading to early disease presentation. Therefore, the influence of specific genetic background, differences in variant penetrance and frequency between populations along with environmental factors may explain this early onset of the disease. Large cohorts of young breast cancer patients should be studied to elucidate these GxE factors.</p>
<p>For ovarian cancer cases, the mean age at diagnosis was 52.62 years and the majority presented with serous ovarian carcinoma. Previous studies have shown that among all patients diagnosed with serous ovarian carcinoma, which is the most common subtype, over 15% will have germline <em>BRCA</em> mutations (<a href="#B39" class="usa-link" aria-describedby="B39">39</a>).</p>
<p>Among the 16 distinct deleterious mutations that have been observed c.19_47del, c.668dupA, c.915T&gt;A, c.1612C&gt;T, c.2418dupA, c.2433delC, c.3049G&gt;T and c.5030_5033delCTAA in <em>BRCA1</em> and c.-227-?_7805+? (Del exons 1-16), c.249delG, c.632-1G&gt;A, c.1389_1390delAG in <em>BRCA2</em>, are reported for the first time in the Tunisian population. We have also identified an inframe deletion reported to have a conflicting interpretation of pathogenicity effect in early onset bilateral breast cancer patient <em>BRCA1</em>_c.5017_5019delCAC. This variation has been described in multiple breast and ovarian cancer cases, with some families showing incomplete co-segregation of the variation (<a href="#B40" class="usa-link" aria-describedby="B40">40</a>–<a href="#B42" class="usa-link" aria-describedby="B42">42</a>).</p>
<p>Among <em>BRCA</em> mutations identified in breast cancer patients <em>BRCA1_c</em>.211dupA, <em>BRCA1</em>_c.5266dupC,<em>BRCA2</em>_c.-227-?_7805+?,<em>BRCA2</em>_1310_1313delAAGA, <em>BRCA2</em>_c.1389_1390delAG and <em>BRCA2</em>_c.7654dupA occurred in BCCRs that are considered to be associated with an increased likelihood of breast cancer compared to ovarian cancer. Considering <em>BRCA</em> mutations identified in ovarian cancer patients <em>BRCA1</em>_c.1612C&gt;T and <em>BRCA1</em>_3049G&gt;T arose in OCCRs. Other mutations, namely c.19_47del, c.668dupA, c.915T&gt;A, c.2418dupA, c.2433delC, c.5030_5033delCTAA in <em>BRCA1</em> and c.249delG, c.632-1G&gt;A in <em>BRCA2</em> do not overlap with previously reported breast or ovarian cancer cluster regions. This could be explained by ethnic differences in <em>BRCA</em> mutation spectrum or it may indicate shared cluster regions for both breast and ovarian cancer.</p>
<p>In the <em>BRCA1</em> gene, the c.19_47del mutation was identified in one breast cancer patient. This mutation was previously described only in the Algerian population (<a href="#B43" class="usa-link" aria-describedby="B43">43</a>). The c.2433delC mutation was described in Korean breast and ovarian patients (<a href="#B44" class="usa-link" aria-describedby="B44">44</a>, <a href="#B45" class="usa-link" aria-describedby="B45">45</a>), and in Mexican patients (<a href="#B46" class="usa-link" aria-describedby="B46">46</a>, <a href="#B47" class="usa-link" aria-describedby="B47">47</a>). The pathogenic c.1612C&gt;T mutation was identified in 4 breast and ovarian cancer patients. This mutation has been identified in Brazilian population (<a href="#B48" class="usa-link" aria-describedby="B48">48</a>), in ovarian cancer patients from Israeli population (<a href="#B49" class="usa-link" aria-describedby="B49">49</a>) and in Macedonian population (<a href="#B50" class="usa-link" aria-describedby="B50">50</a>). We also detected the c.668dupA mutation in one patient. This latter has not been reported in previous studies neither in Tunisia nor in other populations. Nevertheless, it is already listed and classified as pathogenic in ClinVar and predicted to result in the substitution of Alanine to Glycine (p.Ala224Glyfs) which leads to BRCA1 protein truncation. Another new mutation was identified in <em>BRCA1</em> gene, c.2418dupA, that was reported by our group for the first time in the Tunisian population and was not reported previously in other populations (<a href="#B51" class="usa-link" aria-describedby="B51">51</a>). c.3049G&gt;T has been identified in one ovarian cancer patient. This mutation has been reported in Thai patients with non-mucinous epithelial ovarian cancer (<a href="#B52" class="usa-link" aria-describedby="B52">52</a>). The c.5030_5033delCTAA mutation was identified among one patient with breast and ovarian cancers and it is reported in Brazilian population (<a href="#B48" class="usa-link" aria-describedby="B48">48</a>). The c.915T&gt;A mutation is novel and not described in public databases.</p>
<p>In addition to the identification of rare and novel <em>BRCA1</em> mutations, other mutations seem to be recurrent and/or were described in previous Tunisian reports. The c.211dupA mutation was shared by 6 patients belonging to the same geographical origin. This mutation has so far been reported only in hereditary breast/ovarian cancer families of Tunisian origin, particularly in the North-East region, suggesting a founder effect. In order to unravel the genetic specificities of this mutation and to trace its origin a haplotype analysis has been conducted by our group on the North Eastern region (<a href="#B51" class="usa-link" aria-describedby="B51">51</a>). Results have determined the founder haplotype segregating with this mutation and have revealed that it arose in the period of colonization approximately 130 years ago.</p>
<p>The c.5266dupC mutation has been identified among two families. This mutation was previously described in 8 Tunisian breast cancer families (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>, <a href="#B16" class="usa-link" aria-describedby="B16">16</a>, <a href="#B17" class="usa-link" aria-describedby="B17">17</a>, <a href="#B20" class="usa-link" aria-describedby="B20">20</a>). It was originally described as an Ashkenazi founder mutation. Haplotype analysis has shown that this mutation arose approximately 1800 years ago in Northern Europe (<a href="#B53" class="usa-link" aria-describedby="B53">53</a>). Then, it has been reported in several other populations such as, Italian, Russian Slovenian and Greek (<a href="#B54" class="usa-link" aria-describedby="B54">54</a>).</p>
<p>Interestingly for <em>BRCA2</em> gene, 6 breast cancer patients were double heterozygous carrying the two deleterious mutations c.632-1G&gt;A and c.1310_1313delAAGA, and 4 other unrelated patients carried only the c.1310_1313delAAGA mutation including one male breast cancer (MBC). c.632-1G&gt;A mutation appears to be rare in other populations since it was only reported in one patient with prostate cancer in the UK (<a href="#B55" class="usa-link" aria-describedby="B55">55</a>). However, c.1310_1313delAAGA seems to be a founder mutation in Maghrebin countries (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>, <a href="#B17" class="usa-link" aria-describedby="B17">17</a>, <a href="#B56" class="usa-link" aria-describedby="B56">56</a>, <a href="#B57" class="usa-link" aria-describedby="B57">57</a>). It has been also identified in patients with Lebanese (<a href="#B58" class="usa-link" aria-describedby="B58">58</a>), European (<a href="#B59" class="usa-link" aria-describedby="B59">59</a>–<a href="#B62" class="usa-link" aria-describedby="B62">62</a>), African (<a href="#B63" class="usa-link" aria-describedby="B63">63</a>), Asian (<a href="#B64" class="usa-link" aria-describedby="B64">64</a>) and Latino ancestry (<a href="#B65" class="usa-link" aria-describedby="B65">65</a>) as well as in Caribbean cohorts (<a href="#B66" class="usa-link" aria-describedby="B66">66</a>, <a href="#B67" class="usa-link" aria-describedby="B67">67</a>). These results show the genetic heterogeneity of breast and ovarian cancers in Tunisian patients and the admixed origins of <em>BRCA</em> mutations in Tunisia.</p>
<p>In addition, 5 male breast cancer cases were investigated among which 2 carried <em>BRCA2</em> mutations (c.1310_1313delAAGA and c.1389_1390delAG). Male breast cancer is a rare disease accounting for less than 1% of all breast cancer cases and it was previously shown that nearly 90% of MBC arising in <em>BRCA</em> mutation carriers are found to harbor a <em>BRCA2</em> mutation (<a href="#B68" class="usa-link" aria-describedby="B68">68</a>). Unfortunately, being a man with “a women’s disease” makes MBC a disease surrounded by social taboo and lack of awareness especially in underdeveloped countries. Indeed, the treatment of MBC has been extrapolated from the knowledge of female breast cancer, despite the multiple differences in the pathogenesis, biology and genetics of these two disease entities. These evidence make MBC a gender issue that requires more attention from the scientific community.</p>
<p>The introduction of the c.1310_1313delAAGA mutation, that have been encountered in diverse populations, in the Tunisian population could be explained by the immigration of Andalusians in Tunisia which has been intensified after the fall of Granada in 1492 and lasted for two centuries before the total expulsion of all Andalusian Moriscos from the Iberian Peninsula in 1610. The diverse geographical distribution of this mutation may further suggest independent origins as shown for the 4184del4 <em>BRCA1</em> mutation reported to have at least three independent origins in the study of Neuhausen et al. (<a href="#B69" class="usa-link" aria-describedby="B69">69</a>). The c.7654dupA <em>BRCA2</em> gene mutation which was identified in a unique family with a strong family history of breast and ovarian cancer is reported previously and exclusively in Algerian population (<a href="#B70" class="usa-link" aria-describedby="B70">70</a>) and could be therefore specific to North African countries.</p>
<p>Through this report and despite the identification of novel mutations in Tunisian population, it is clear that the genetic susceptibility to breast cancer is explained in a vast majority of cases by recurrent mutations. Indeed, more than 44.44% of carriers harbor <em>BRCA1</em>-c.211dupA or <em>BRCA2</em>-1310_1313deAAGA mutations which highlights the importance of screening these mutations in the treatment workflow of cases with early onset or strong family history of breast cancer. In fact, identifying germline <em>BRCA1</em> and <em>BRCA2</em> pathogenic mutations is a crucial component in the medical management of affected patients. Regular surveillance and/or prophylactic mastectomy of the second breast or prophylactic salpingo oophorectomies, which have been shown to reduce the risk of developing cancer, are recommended to these carriers. Moreover, relatives who test positive for a germline <em>BRCA</em> pathogenic mutation may take appropriate action to prevent cancer or have cancer diagnosed as early as possible for better treatment options (<a href="#B59" class="usa-link" aria-describedby="B59">59</a>).</p>
<p>In addition, mutations in the <em>BRCA</em> genes and their associations with clinico-pathological features were reported in several studies (<a href="#B71" class="usa-link" aria-describedby="B71">71</a>–<a href="#B74" class="usa-link" aria-describedby="B74">74</a>). However, in Tunisia this aspect was not previously investigated. This point was raised in the present study and our results showed that patients with <em>BRCA1</em> and <em>BRCA2</em> mutations were similar with regard to several epidemiological and clinico-pathological parameters. Nevertheless, <em>BRCA1</em> carriers were more likely to be triple negative breast cancer compared to <em>BRCA2</em> carriers (p=0.002) and <em>BRCA2</em> carriers were more likely to be luminal B breast cancer tumors (p=0.000078). Consistent with our findings, various previous studies reported that there is a much higher rate of TNBC among <em>BRCA1</em> mutation carriers (<a href="#B75" class="usa-link" aria-describedby="B75">75</a>, <a href="#B76" class="usa-link" aria-describedby="B76">76</a>) and <em>BRCA2</em>-related breast cancer is often luminal (<a href="#B77" class="usa-link" aria-describedby="B77">77</a>). Additionally, positive ER was significantly associated with <em>BRCA2+</em> tumors (p=0.000056). PR status was significantly different between <em>BRCA1</em> and <em>BRCA2</em> mutation carriers; <em>BRCA2</em> carriers are more likely to develop progesterone receptor (PR) positive tumors and PR-negative breast cancer are associated with <em>BRCA1</em> mutation carriers (p=0.000084). It was reported that the ER positivity was predominantly seen in <em>BRCA2</em> mutation carriers, which is consistent with our findings (<a href="#B71" class="usa-link" aria-describedby="B71">71</a>, <a href="#B78" class="usa-link" aria-describedby="B78">78</a>). Furthermore, a previous report has found that <em>BRCA2</em>-associated cancers are mainly PR positive (<a href="#B79" class="usa-link" aria-describedby="B79">79</a>). Other studies have raised some pathological differences between <em>BRCA1/2</em> mutation carriers and <em>BRCAx</em> patients. In our study, <em>BRCA</em> carriers seem to be younger than <em>BRCA-negative</em> patients (p=0.049). Furthermore, patients with a positive family history of ovarian cancer are more likely to be <em>BRCA</em> positive (p=0.004). We also observed a significant predominance of SBR grade III tumors among <em>BRCA1/2</em> mutations carriers (p= 0.027). These findings are in line with previous literature  (<a href="#B35" class="usa-link" aria-describedby="B35">35</a>, <a href="#B80" class="usa-link" aria-describedby="B80">80</a>, <a href="#B81" class="usa-link" aria-describedby="B81">81</a>).</p>
<p>Furthermore, we have assessed disease outcomes in <em>BRCA</em> carriers, and we have observed a relatively high proportion of contralateral breast cancer and ovarian cancer occurrence that were more frequently observed in <em>BRCA1</em> carriers. Previous reports have demonstrated that women carrying a pathogenic mutation in the <em>BRCA1</em> or <em>BRCA2</em> genes have an increased risk of developing a second primary cancer in the contralateral breast. The cumulative risk 20 years after breast cancer diagnosis was estimated to be 40% for <em>BRCA1</em> carriers and about 26% for <em>BRCA2</em> carriers (<a href="#B82" class="usa-link" aria-describedby="B82">82</a>). In accordance with our findings, it was shown also that the occurrence of both breast and ovarian cancer in a woman is associated with a high likelihood of a germline <em>BRCA1</em> mutation (<a href="#B83" class="usa-link" aria-describedby="B83">83</a>).</p>
<p>Besides the <em>BRCA</em> genetic mutations that have been identified in our study, mutations on other high to moderate breast cancer genes such as <em>TP53</em>, <em>ATM, BLM</em> and <em>CHEK2</em> have been also identified for the first time in North African populations (data not shown). All these findings reflect the genetic heterogeneity of cancer predisposition in Tunisia and highlights the importance of the use of NGS to identify clinically actionable genetic variants that have a crucial role in disease management. Therefore, technological advances in terms of array and DNA sequencing technologies made the route towards the examination of genetic risk largely clear. However, practical challenges related to marked population-specific differences still exist. In this context, Manolio and colleagues conveniently classified <em>LRRK2</em> as a high penetrant gene associated with Parkinson disease (<a href="#B84" class="usa-link" aria-describedby="B84">84</a>) with G2019S mutation being the main cause of Parkinson familial cases. Recently the international LRRK2 consortium reported a worldwide frequency of 1% of <em>LRRK2</em> G2019S, 30–40% in Arab patients from North Africa and 10–30% in Ashkenazi Jews, but is very rare in Asians (<a href="#B85" class="usa-link" aria-describedby="B85">85</a>, <a href="#B86" class="usa-link" aria-describedby="B86">86</a>). As a variant´s frequency has a direct impact on its penetrance, this example shows the ethnic-dependent penetrance of some important variants involved in complex diseases and the role of consanguinity and endogamy in shaping the genetic susceptibility to these diseases. Therefore, the same reflection can be applied on high and low penetrant breast cancer variants in order to review their penetrance in underrepresented populations such as North Africans. A disproportionate distribution of the identified mutations is observed between the Northern and Southern regions of Tunisia (<a href="#f2" class="usa-link"><strong>Figure 2</strong></a>), with the vast majority found in the North. This can be explained by a selection bias because most of the recruited participants come from Northern governorates, but it can also be explained by the very high consanguinity rates in the South that reaches 98% in some cities and that may have an impact on <em>BRCA</em> mutations frequency and prevalence.</p>
<p>Additional limitations of our study have been observed. Indeed, to our best knowledge, this work represents the largest BRCA1/2 study in Africa. However, we believe that the sample size is still small and larger cohorts are needed to trace a clear and complete BRCA1/2 mutational spectrum in Tunisia. In addition, because of the limited resources dedicated to this work, we were not able to perform a complete sequencing of both genes for the whole cohort. Therefore, the frequency and prevalence of the identified mutations need to be assessed in larger studies. Clearly, the prevalence assessment of <em>BRCA1</em> and <em>BRCA2</em> mutations also rely on the quality of both cohort selection criteria and mutation ascertainment methods. The identification of novel BRCA mutations and the assessment of their penetrance in a specific population will help to implement more affordable and cost effective targeted genetic testing strategies.</p>
<p>Finally, up until now, most data on <em>BRCA1</em>/2 mutations associated with high risk for hereditary breast and ovarian cancer do not cover the North African populations. Accordingly, the novel mutations identified in this study will help to improve knowledge on the genetic component of hereditary breast and ovarian cancer in the North African region and will lead to a better clinical management of cancer patients. In addition, we are aiming to share genetic and phenotypic data with larger multi-ethnic Consortia of <em>BRCA1/2</em> mutation carriers such as the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) (<a href="#B87" class="usa-link" aria-describedby="B87">87</a>). This will make our findings more broadly useful and will give us a global overview of the similarities and differences that the Tunisian population has compared to other ethnicities.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>In conclusion we have identified 16 distinct <em>BRCA</em> mutations in breast and ovarian cancer patients including 11 novel mutations in the Tunisian population. The recognition of the <em>BRCA</em> mutational spectrum and its geographical distribution in Tunisia is of keen interest for the scientific and medical communities as it helps to develop precise risk assessment tools, accurate genetic testing, cost-effective approaches for prevention and early detection of the disease as well as personalized treatments of <em>BRCA</em> related cancers for both affected and unaffected cancer cases.</p></section><section id="s6"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in this study are included in this article and in its supplementary files. All identified mutations with their related details have been shared in the public database ClinVar under the following link “<a href="https://www.ncbi.nlm.nih.gov/clinvar/submitters/507986/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/submitters/507986/</a>”. Any additional datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The studies involving human participants were reviewed and approved by The Biomedical Ethics Committee of Institut Pasteur de Tunis (2017/16/E/Hôpital A-M). The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from participants for the publication of any potentially identifiable images or data included in this article.</p></section><section id="s8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>YH prepared the study concept and design, supervised the study, did data analysis, data interpretation, drafted, and critically revised the manuscript. NMi and MB did the experiments, participated in participant recruitment, and participated in drafting and reviewing the manuscript. NMe contributed to clinical data analysis and reviewed the manuscript. SN contributed to participants recruitment and reviewed the manuscript. MR and OM contributed to data collection and reviewed the manuscript. HanB, YB, HR, OJ, ND, AZ, JA, HEB, SL and JBH contributed to the clinical investigation and recruitment of patients. AH, KR, FB, RM, SBA and HamB critically revised the clinicopathological section and the whole manuscript. SB and SA contributed to the study concept, design and supervision and critically revised the manuscript. All authors contributed to the article and approved the submitted version.</p></section><section id="s9"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the Tunisian Ministry of Higher Education and Scientific Research (LR16IPT05) and the Tunisian Ministry of Public Health (PEC-4-TUN). MB and MBR are recipient of a MOBIDOC fellowship funded by the EU through the EMORI and PASRI programs managed by the ANPR.</p></section><section id="s10"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s11"><h2 class="pmc_sec_title">Publisher’s Note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This manuscript is dedicated to the memory of Prof. Farouk Benna, an imminent radiotherapist who died from Covid19 when ensuring his medical activity. We would like to thank Dr. Zied Zidi, Dr Ghazi Jerbi, Dr Samir Khalfallah, Dr Monia Hechiche, Dr Achraf Chaari, Dr Olfa gharbi, Dr Monia Hechiche, Dr Sami Bellil, Dr Ichraf Jbir, Dr Olfa Daldoul Ben Fraj, Dr Bassem Allani/Dr David Khayat, Dr Tarek Bouzid, Dr El Fatmi Rym/Dr Mokrani Amina, Dr Samia Chatti Dey, Dr Hatem Chaaba, Dr Med Ali Ayadi, Dr Lotfi Kochbati, Dr Fethi Messoudi and Dr Chadha Elward Abdelhedi for their contribution in this work. We are also grateful to all participants and their family members for their participation in the study.</p></section><section id="s12"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fonc.2021.674965/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fonc.2021.674965/full#supplementary-material</a></p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/8417726/bin/Table_1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (659.1KB, docx) </sup>
</div></div></section></section><section id="s13"><h2 class="pmc_sec_title">Abbreviations</h2>
<p>BCCRs, Breast Cancer Cluster Regions; ER, Estrogen receptor; gDNA, Genomic DNA; GxE, Genetic and Environmental factors; IDC, Invasive Ductal Carcinoma; LMICs, Low- and middle-income countries; OCCRs, Ovarian cancer cluster regions; PR, Progesterone receptor; SBR, Scarff-Bloom-Richardson; TNBC, Triple Negative Breast Cancer; VUS, Variants of Unknown Significance; WES, Whole Exome Sequencing.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: Cancer J Clin (2018) 68(6):394–424. 10.3322/caac.21492
</cite> [<a href="https://doi.org/10.3322/caac.21492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30207593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA:%20Cancer%20J%20Clin&amp;title=Global%20Cancer%20Statistics%202018:%20GLOBOCAN%20Estimates%20of%20Incidence%20and%20Mortality%20Worldwide%20for%2036%20Cancers%20in%20185%20Countries&amp;author=F%20Bray&amp;author=J%20Ferlay&amp;author=I%20Soerjomataram&amp;author=RL%20Siegel&amp;author=LA%20Torre&amp;volume=68&amp;issue=6&amp;publication_year=2018&amp;pages=394-424&amp;pmid=30207593&amp;doi=10.3322/caac.21492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Chalabi N, Bernard-Gallon DJ, Bignon YJ, Breast Med C, Kwiatkowski F, Agier M, et al. Comparative Clinical and Transcriptomal Profiles of Breast Cancer Between French and South Mediterranean Patients Show Minor But Significative Biological Differences. Cancer Genomics Proteomics (2008) 5(5):253–61.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/19129556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genomics%20Proteomics&amp;title=Comparative%20Clinical%20and%20Transcriptomal%20Profiles%20of%20Breast%20Cancer%20Between%20French%20and%20South%20Mediterranean%20Patients%20Show%20Minor%20But%20Significative%20Biological%20Differences&amp;author=N%20Chalabi&amp;author=DJ%20Bernard-Gallon&amp;author=YJ%20Bignon&amp;author=C%20Breast%20Med&amp;author=F%20Kwiatkowski&amp;volume=5&amp;issue=5&amp;publication_year=2008&amp;pmid=19129556&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Boussen H, Bouzaiene H, Ben Hassouna J, Dhiab T, Khomsi F, Benna F, et al. Inflammatory Breast Cancer in Tunisia: Epidemiological and Clinical Trends. Cancer (2010) 116(11 Suppl):2730–5. 10.1002/cncr.25175
</cite> [<a href="https://doi.org/10.1002/cncr.25175" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20503401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Inflammatory%20Breast%20Cancer%20in%20Tunisia:%20Epidemiological%20and%20Clinical%20Trends&amp;author=H%20Boussen&amp;author=H%20Bouzaiene&amp;author=J%20Ben%20Hassouna&amp;author=T%20Dhiab&amp;author=F%20Khomsi&amp;volume=116&amp;issue=11%20Suppl&amp;publication_year=2010&amp;pmid=20503401&amp;doi=10.1002/cncr.25175&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average Risks of Breast and Ovarian Cancer Associated With BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies. Am J Hum Genet (2003) 72(5):1117–30. 10.1086/375033
</cite> [<a href="https://doi.org/10.1086/375033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1180265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12677558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Average%20Risks%20of%20Breast%20and%20Ovarian%20Cancer%20Associated%20With%20BRCA1%20or%20BRCA2%20Mutations%20Detected%20in%20Case%20Series%20Unselected%20for%20Family%20History:%20A%20Combined%20Analysis%20of%2022%20Studies&amp;author=A%20Antoniou&amp;author=PD%20Pharoah&amp;author=S%20Narod&amp;author=HA%20Risch&amp;author=JE%20Eyfjord&amp;volume=72&amp;issue=5&amp;publication_year=2003&amp;pmid=12677558&amp;doi=10.1086/375033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, et al. Cancers Associated With BRCA 1 and BRCA 2 Mutations Other Than Breast and Ovarian. Cancer (2015) 121(2):269–75. 10.1002/cncr.29041
</cite> [<a href="https://doi.org/10.1002/cncr.29041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4293332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25224030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Cancers%20Associated%20With%20BRCA%201%20and%20BRCA%202%20Mutations%20Other%20Than%20Breast%20and%20Ovarian&amp;author=J%20Mersch&amp;author=MA%20Jackson&amp;author=M%20Park&amp;author=D%20Nebgen&amp;author=SK%20Peterson&amp;volume=121&amp;issue=2&amp;publication_year=2015&amp;pmid=25224030&amp;doi=10.1002/cncr.29041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, et al. Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality. JAMA (2010) 304(9):967–75. 10.1001/jama.2010.1237
</cite> [<a href="https://doi.org/10.1001/jama.2010.1237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2948529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20810374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20of%20Risk-Reducing%20Surgery%20in%20BRCA1%20or%20BRCA2%20Mutation%20Carriers%20With%20Cancer%20Risk%20and%20Mortality&amp;author=SM%20Domchek&amp;author=TM%20Friebel&amp;author=CF%20Singer&amp;author=DG%20Evans&amp;author=HT%20Lynch&amp;volume=304&amp;issue=9&amp;publication_year=2010&amp;pmid=20810374&amp;doi=10.1001/jama.2010.1237&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, et al. Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations. N Engl J Med (2002) 346(21):1616–22. 10.1056/NEJMoa012158
</cite> [<a href="https://doi.org/10.1056/NEJMoa012158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12023993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Prophylactic%20Oophorectomy%20in%20Carriers%20of%20BRCA1%20or%20BRCA2%20Mutations&amp;author=TR%20Rebbeck&amp;author=HT%20Lynch&amp;author=SL%20Neuhausen&amp;author=SA%20Narod&amp;author=L%20Van't%20Veer&amp;volume=346&amp;issue=21&amp;publication_year=2002&amp;pmid=12023993&amp;doi=10.1056/NEJMoa012158&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Menkiszak J, Chudecka-Glaz A, Gronwald J, Cymbaluk-Ploska A, Celewicz A, Swiniarska M, et al. Prophylactic Salpingo-Oophorectomy in BRCA1 Mutation Carriers and Postoperative Incidence of Peritoneal and Breast Cancers. J Ovarian Res (2016) 9:11. 10.1186/s13048-016-0220-4
</cite> [<a href="https://doi.org/10.1186/s13048-016-0220-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4772302/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26928677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Ovarian%20Res&amp;title=Prophylactic%20Salpingo-Oophorectomy%20in%20BRCA1%20Mutation%20Carriers%20and%20Postoperative%20Incidence%20of%20Peritoneal%20and%20Breast%20Cancers&amp;author=J%20Menkiszak&amp;author=A%20Chudecka-Glaz&amp;author=J%20Gronwald&amp;author=A%20Cymbaluk-Ploska&amp;author=A%20Celewicz&amp;volume=9&amp;publication_year=2016&amp;pages=11&amp;pmid=26928677&amp;doi=10.1186/s13048-016-0220-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Turner NC, Tutt AN. Platinum Chemotherapy for BRCA1-Related Breast Cancer: Do We Need More Evidence? Breast Cancer Res (2012) 14(6):115. 10.1186/bcr3332
</cite> [<a href="https://doi.org/10.1186/bcr3332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4053124/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23146216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=Platinum%20Chemotherapy%20for%20BRCA1-Related%20Breast%20Cancer:%20Do%20We%20Need%20More%20Evidence&amp;author=NC%20Turner&amp;author=AN%20Tutt&amp;volume=14&amp;issue=6&amp;publication_year=2012&amp;pages=115&amp;pmid=23146216&amp;doi=10.1186/bcr3332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Mateo J, Lord CJ, Serra V, Tutt A, Balmana J, Castroviejo-Bermejo M, et al. A Decade of Clinical Development of PARP Inhibitors in Perspective. Ann Oncol (2019) 30(9):1437–47. 10.1093/annonc/mdz192
</cite> [<a href="https://doi.org/10.1093/annonc/mdz192" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6771225/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31218365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=A%20Decade%20of%20Clinical%20Development%20of%20PARP%20Inhibitors%20in%20Perspective&amp;author=J%20Mateo&amp;author=CJ%20Lord&amp;author=V%20Serra&amp;author=A%20Tutt&amp;author=J%20Balmana&amp;volume=30&amp;issue=9&amp;publication_year=2019&amp;pmid=31218365&amp;doi=10.1093/annonc/mdz192&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Mahfoudh W, Bouaouina N, Ahmed SB, Gabbouj S, Shan J, Mathew R, et al. Hereditary Breast Cancer in Middle Eastern and North African (MENA) Populations: Identification of Novel, Recurrent and Founder BRCA1 Mutations in the Tunisian Population. Mol Biol Rep (2012) 39(2):1037–46. 10.1007/s11033-011-0829-8
</cite> [<a href="https://doi.org/10.1007/s11033-011-0829-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3249560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21603858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Biol%20Rep&amp;title=Hereditary%20Breast%20Cancer%20in%20Middle%20Eastern%20and%20North%20African%20(MENA)%20Populations:%20Identification%20of%20Novel,%20Recurrent%20and%20Founder%20BRCA1%20Mutations%20in%20the%20Tunisian%20Population&amp;author=W%20Mahfoudh&amp;author=N%20Bouaouina&amp;author=SB%20Ahmed&amp;author=S%20Gabbouj&amp;author=J%20Shan&amp;volume=39&amp;issue=2&amp;publication_year=2012&amp;pmid=21603858&amp;doi=10.1007/s11033-011-0829-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Kadouri L, Hubert A, Rotenberg Y, Hamburger T, Sagi M, Nechushtan C, et al. Cancer Risks in Carriers of the BRCA1/2 Ashkenazi Founder Mutations. J Med Genet (2007) 44(7):467–71. 10.1136/jmg.2006.048173
</cite> [<a href="https://doi.org/10.1136/jmg.2006.048173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2598014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17307836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Cancer%20Risks%20in%20Carriers%20of%20the%20BRCA1/2%20Ashkenazi%20Founder%20Mutations&amp;author=L%20Kadouri&amp;author=A%20Hubert&amp;author=Y%20Rotenberg&amp;author=T%20Hamburger&amp;author=M%20Sagi&amp;volume=44&amp;issue=7&amp;publication_year=2007&amp;pmid=17307836&amp;doi=10.1136/jmg.2006.048173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Fackenthal JD, Olopade OI. Breast Cancer Risk Associated With BRCA1 and BRCA2 in Diverse Populations. Nat Rev Cancer (2007) 7(12):937–48. 10.1038/nrc2054
</cite> [<a href="https://doi.org/10.1038/nrc2054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18034184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Breast%20Cancer%20Risk%20Associated%20With%20BRCA1%20and%20BRCA2%20in%20Diverse%20Populations&amp;author=JD%20Fackenthal&amp;author=OI%20Olopade&amp;volume=7&amp;issue=12&amp;publication_year=2007&amp;pmid=18034184&amp;doi=10.1038/nrc2054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Ramus SJ, Gayther SA. The Contribution of BRCA1 and BRCA2 to Ovarian Cancer. Mol Oncol (2009) 3(2):138–50. 10.1016/j.molonc.2009.02.001
</cite> [<a href="https://doi.org/10.1016/j.molonc.2009.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5527889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19383375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Oncol&amp;title=The%20Contribution%20of%20BRCA1%20and%20BRCA2%20to%20Ovarian%20Cancer&amp;author=SJ%20Ramus&amp;author=SA%20Gayther&amp;volume=3&amp;issue=2&amp;publication_year=2009&amp;pmid=19383375&amp;doi=10.1016/j.molonc.2009.02.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Mestiri S, Monastiri K, Ben SA, Bouaouina N, Presneau N, Bignon Y, et al. Mutational Analysis of Breast/Ovarian Cancer Hereditary Predisposition Gene BRCA1 in Tunisian Women. Arch l'Institut Pasteur Tunis (2000) 77(1-4):11–5.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/14658222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20l'Institut%20Pasteur%20Tunis&amp;title=Mutational%20Analysis%20of%20Breast/Ovarian%20Cancer%20Hereditary%20Predisposition%20Gene%20BRCA1%20in%20Tunisian%20Women&amp;author=S%20Mestiri&amp;author=K%20Monastiri&amp;author=SA%20Ben&amp;author=N%20Bouaouina&amp;author=N%20Presneau&amp;volume=77&amp;issue=1-4&amp;publication_year=2000&amp;pmid=14658222&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Troudi W, Uhrhammer N, Sibille C, Dahan C, Mahfoudh W, Bouchlaka Souissi C, et al. Contribution of the BRCA1 and BRCA2 Mutations to Breast Cancer in Tunisia. J Hum Genet (2007) 52(11):915–20. 10.1007/s10038-007-0195-5
</cite> [<a href="https://doi.org/10.1007/s10038-007-0195-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17922257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hum%20Genet&amp;title=Contribution%20of%20the%20BRCA1%20and%20BRCA2%20Mutations%20to%20Breast%20Cancer%20in%20Tunisia&amp;author=W%20Troudi&amp;author=N%20Uhrhammer&amp;author=C%20Sibille&amp;author=C%20Dahan&amp;author=W%20Mahfoudh&amp;volume=52&amp;issue=11&amp;publication_year=2007&amp;pmid=17922257&amp;doi=10.1007/s10038-007-0195-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Fourati A, Louchez MM, Fournier J, Gamoudi A, Rahal K, El May MV, et al. Screening for Common Mutations in BRCA1 and BRCA2 Genes: Interest in Genetic Testing of Tunisian Families With Breast and/or Ovarian Cancer. Bull Cancer (2014) 101(11):E36–40. 10.1684/bdc.2014.2049
</cite> [<a href="https://doi.org/10.1684/bdc.2014.2049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25418591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bull%20Cancer&amp;title=Screening%20for%20Common%20Mutations%20in%20BRCA1%20and%20BRCA2%20Genes:%20Interest%20in%20Genetic%20Testing%20of%20Tunisian%20Families%20With%20Breast%20and/or%20Ovarian%20Cancer&amp;author=A%20Fourati&amp;author=MM%20Louchez&amp;author=J%20Fournier&amp;author=A%20Gamoudi&amp;author=K%20Rahal&amp;volume=101&amp;issue=11&amp;publication_year=2014&amp;pmid=25418591&amp;doi=10.1684/bdc.2014.2049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Msolly A. BRCA1 and BRCA2 Mutations Are They Related to Breast Cancer in a Sample of Tunisian Population? Cancer Ther Oncol Int J (2015) 1(1):1–5. 10.19080/CTOIJ.2015.01.555551
</cite> [<a href="https://doi.org/10.19080/CTOIJ.2015.01.555551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Ther%20Oncol%20Int%20J&amp;title=BRCA1%20and%20BRCA2%20Mutations%20Are%20They%20Related%20to%20Breast%20Cancer%20in%20a%20Sample%20of%20Tunisian%20Population&amp;author=A%20Msolly&amp;volume=1&amp;issue=1&amp;publication_year=2015&amp;pages=1-5&amp;doi=10.19080/CTOIJ.2015.01.555551&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Riahi A, Chabouni-Bouhamed H, Kharrat M. Prevalence of BRCA1 and BRCA2 Large Genomic Rearrangements in Tunisian High Risk Breast/Ovarian Cancer Families: Implications for Genetic Testing. Cancer Genet (2017) 210:22–7. 10.1016/j.cancergen.2016.11.002
</cite> [<a href="https://doi.org/10.1016/j.cancergen.2016.11.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28212807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet&amp;title=Prevalence%20of%20BRCA1%20and%20BRCA2%20Large%20Genomic%20Rearrangements%20in%20Tunisian%20High%20Risk%20Breast/Ovarian%20Cancer%20Families:%20Implications%20for%20Genetic%20Testing&amp;author=A%20Riahi&amp;author=H%20Chabouni-Bouhamed&amp;author=M%20Kharrat&amp;volume=210&amp;publication_year=2017&amp;pmid=28212807&amp;doi=10.1016/j.cancergen.2016.11.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Riahi A, Kharrat M, Ghourabi ME, Khomsi F, Gamoudi A, Lariani I, et al. Mutation Spectrum and Prevalence of BRCA1 and BRCA2 Genes in Patients With Familial and Early-Onset Breast/Ovarian Cancer From Tunisia. Clin Genet (2015) 87(2):155–60. 10.1111/cge.12337
</cite> [<a href="https://doi.org/10.1111/cge.12337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24372583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Genet&amp;title=Mutation%20Spectrum%20and%20Prevalence%20of%20BRCA1%20and%20BRCA2%20Genes%20in%20Patients%20With%20Familial%20and%20Early-Onset%20Breast/Ovarian%20Cancer%20From%20Tunisia&amp;author=A%20Riahi&amp;author=M%20Kharrat&amp;author=ME%20Ghourabi&amp;author=F%20Khomsi&amp;author=A%20Gamoudi&amp;volume=87&amp;issue=2&amp;publication_year=2015&amp;pmid=24372583&amp;doi=10.1111/cge.12337&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Hadiji-Abbes N, Trifa F, Choura M, Khabir A, Sellami-Boudawara T, Frikha M, et al. A Novel BRCA2 in Frame Deletion in a Tunisian Woman With Early Onset Sporadic Breast Cancer. Pathol Biol (Paris) (2015) 63(4-5):185–9. 10.1016/j.patbio.2015.07.009
</cite> [<a href="https://doi.org/10.1016/j.patbio.2015.07.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26320393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathol%20Biol%20(Paris)&amp;title=A%20Novel%20BRCA2%20in%20Frame%20Deletion%20in%20a%20Tunisian%20Woman%20With%20Early%20Onset%20Sporadic%20Breast%20Cancer&amp;author=N%20Hadiji-Abbes&amp;author=F%20Trifa&amp;author=M%20Choura&amp;author=A%20Khabir&amp;author=T%20Sellami-Boudawara&amp;volume=63&amp;issue=4-5&amp;publication_year=2015&amp;pmid=26320393&amp;doi=10.1016/j.patbio.2015.07.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Mahfoudh W, Bettaieb I, Ghedira R, Snoussi K, Bouzid N, Klayech Z, et al. Contribution of BRCA1 5382insc Mutation in Triple Negative Breast Cancer in Tunisia. J Trans Med (2019) 17(1):123. 10.1186/s12967-019-1873-8
</cite> [<a href="https://doi.org/10.1186/s12967-019-1873-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6458830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30975216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Trans%20Med&amp;title=Contribution%20of%20BRCA1%205382insc%20Mutation%20in%20Triple%20Negative%20Breast%20Cancer%20in%20Tunisia&amp;author=W%20Mahfoudh&amp;author=I%20Bettaieb&amp;author=R%20Ghedira&amp;author=K%20Snoussi&amp;author=N%20Bouzid&amp;volume=17&amp;issue=1&amp;publication_year=2019&amp;pages=123&amp;pmid=30975216&amp;doi=10.1186/s12967-019-1873-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Ben Kridis-Rejeb W, Ben Ayed-Guerfali D, Ammous-Boukhris N, Ayadi W, Kifagi C, Charfi S, et al. Identification of Novel Candidate Genes by Exome Sequencing in Tunisian Familial Male Breast Cancer Patients. Mol Biol Rep (2020) 47(9):6507–16. 10.1007/s11033-020-05703-0
</cite> [<a href="https://doi.org/10.1007/s11033-020-05703-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32901360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Biol%20Rep&amp;title=Identification%20of%20Novel%20Candidate%20Genes%20by%20Exome%20Sequencing%20in%20Tunisian%20Familial%20Male%20Breast%20Cancer%20Patients&amp;author=W%20Ben%20Kridis-Rejeb&amp;author=D%20Ben%20Ayed-Guerfali&amp;author=N%20Ammous-Boukhris&amp;author=W%20Ayadi&amp;author=C%20Kifagi&amp;volume=47&amp;issue=9&amp;publication_year=2020&amp;pmid=32901360&amp;doi=10.1007/s11033-020-05703-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of Protein-Coding Genetic Variation in 60,706 Humans. Nature (2016) 536(7616):285–91. 10.1038/nature19057
</cite> [<a href="https://doi.org/10.1038/nature19057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5018207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27535533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Analysis%20of%20Protein-Coding%20Genetic%20Variation%20in%2060,706%20Humans&amp;author=M%20Lek&amp;author=KJ%20Karczewski&amp;author=EV%20Minikel&amp;author=KE%20Samocha&amp;author=E%20Banks&amp;volume=536&amp;issue=7616&amp;publication_year=2016&amp;pmid=27535533&amp;doi=10.1038/nature19057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A Global Reference for Human Genetic Variation. Nature (2015) 526(7571):68–74. 10.1038/nature15393
</cite> [<a href="https://doi.org/10.1038/nature15393" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4750478/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26432245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A%20Global%20Reference%20for%20Human%20Genetic%20Variation&amp;author=C%20Genomes%20Project&amp;author=A%20Auton&amp;author=LD%20Brooks&amp;author=RM%20Durbin&amp;author=EP%20Garrison&amp;volume=526&amp;issue=7571&amp;publication_year=2015&amp;pages=68-74&amp;pmid=26432245&amp;doi=10.1038/nature15393&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, et al. Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer. JAMA (2015) 313(13):1347–61. 10.1001/jama.2014.5985
</cite> [<a href="https://doi.org/10.1001/jama.2014.5985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4537700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25849179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20of%20Type%20and%20Location%20of%20BRCA1%20and%20BRCA2%20Mutations%20With%20Risk%20of%20Breast%20and%20Ovarian%20Cancer&amp;author=TR%20Rebbeck&amp;author=N%20Mitra&amp;author=F%20Wan&amp;author=OM%20Sinilnikova&amp;author=S%20Healey&amp;volume=313&amp;issue=13&amp;publication_year=2015&amp;pmid=25849179&amp;doi=10.1001/jama.2014.5985&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Melchor L, Benitez J. The Complex Genetic Landscape of Familial Breast Cancer. Hum Genet (2013) 132(8):845–63. 10.1007/s00439-013-1299-y
</cite> [<a href="https://doi.org/10.1007/s00439-013-1299-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23552954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Genet&amp;title=The%20Complex%20Genetic%20Landscape%20of%20Familial%20Breast%20Cancer&amp;author=L%20Melchor&amp;author=J%20Benitez&amp;volume=132&amp;issue=8&amp;publication_year=2013&amp;pmid=23552954&amp;doi=10.1007/s00439-013-1299-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Laraqui A, Uhrhammer N, Rhaffouli HE, Sekhsokh Y, Lahlou-Amine I, Bajjou T, et al. BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (C.798_799deltt) in North African. Dis Markers (2015) 2015:194293. 10.1155/2015/194293
</cite> [<a href="https://doi.org/10.1155/2015/194293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4359853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25814778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis%20Markers&amp;title=BRCA%20Genetic%20Screening%20in%20Middle%20Eastern%20and%20North%20African:%20Mutational%20Spectrum%20and%20Founder%20BRCA1%20Mutation%20(C.798_799deltt)%20in%20North%20African&amp;author=A%20Laraqui&amp;author=N%20Uhrhammer&amp;author=HE%20Rhaffouli&amp;author=Y%20Sekhsokh&amp;author=I%20Lahlou-Amine&amp;volume=2015&amp;publication_year=2015&amp;pages=194293&amp;pmid=25814778&amp;doi=10.1155/2015/194293&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Laitman Y, Friebel TM, Yannoukakos D, Fostira F, Konstantopoulou I, Figlioli G, et al. The Spectrum of BRCA1 and BRCA2 Pathogenic Sequence Variants in Middle Eastern, North African, and South European Countries. Hum Mutat (2019) 40(11):e1–e23. 10.1002/humu.23842
</cite> [<a href="https://doi.org/10.1002/humu.23842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31209999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=The%20Spectrum%20of%20BRCA1%20and%20BRCA2%20Pathogenic%20Sequence%20Variants%20in%20Middle%20Eastern,%20North%20African,%20and%20South%20European%20Countries&amp;author=Y%20Laitman&amp;author=TM%20Friebel&amp;author=D%20Yannoukakos&amp;author=F%20Fostira&amp;author=I%20Konstantopoulou&amp;volume=40&amp;issue=11&amp;publication_year=2019&amp;pages=e1-e23&amp;pmid=31209999&amp;doi=10.1002/humu.23842&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Behl S, Hamel N, de Ladurantaye M, Lepage S, Lapointe R, Mes-Masson AM, et al. Founder BRCA1/BRCA2/PALB2 Pathogenic Variants in French-Canadian Breast Cancer Cases and Controls. Sci Rep (2020) 10(1):6491. 10.1038/s41598-020-63100-w
</cite> [<a href="https://doi.org/10.1038/s41598-020-63100-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7162921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32300229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Founder%20BRCA1/BRCA2/PALB2%20Pathogenic%20Variants%20in%20French-Canadian%20Breast%20Cancer%20Cases%20and%20Controls&amp;author=S%20Behl&amp;author=N%20Hamel&amp;author=M%20de%20Ladurantaye&amp;author=S%20Lepage&amp;author=R%20Lapointe&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=6491&amp;pmid=32300229&amp;doi=10.1038/s41598-020-63100-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Oosthuizen J, Kotze MJ, van der Merwe N, Myburgh EJ, Bester P, van der Merwe NC. Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-Of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study. Front Oncol (2020) 10:619469. 10.3389/fonc.2020.619469
</cite> [<a href="https://doi.org/10.3389/fonc.2020.619469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7908826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33643918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Globally%20Rare%20BRCA2%20Variants%20With%20Founder%20Haplotypes%20in%20the%20South%20African%20Population:%20Implications%20for%20Point-Of-Care%20Testing%20Based%20on%20a%20Single-Institution%20BRCA1/2%20Next-Generation%20Sequencing%20Study&amp;author=J%20Oosthuizen&amp;author=MJ%20Kotze&amp;author=N%20van%20der%20Merwe&amp;author=EJ%20Myburgh&amp;author=P%20Bester&amp;volume=10&amp;publication_year=2020&amp;pages=619469&amp;pmid=33643918&amp;doi=10.3389/fonc.2020.619469&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Tennen RI, Laskey SB, Koelsch BL, McIntyre MH, Tung JY. Identifying Ashkenazi Jewish BRCA1/2 Founder Variants in Individuals Who Do Not Self-Report Jewish Ancestry. Sci Rep (2020) 10(1):7669. 10.1038/s41598-020-63466-x
</cite> [<a href="https://doi.org/10.1038/s41598-020-63466-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7203114/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32376921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Identifying%20Ashkenazi%20Jewish%20BRCA1/2%20Founder%20Variants%20in%20Individuals%20Who%20Do%20Not%20Self-Report%20Jewish%20Ancestry&amp;author=RI%20Tennen&amp;author=SB%20Laskey&amp;author=BL%20Koelsch&amp;author=MH%20McIntyre&amp;author=JY%20Tung&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=7669&amp;pmid=32376921&amp;doi=10.1038/s41598-020-63466-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>Hamdi Y, Ben Rekaya M, Jingxuan S, Nagara M, Messaoud O, Benammar Elgaaied A, et al. A Genome Wide SNP Genotyping Study in the Tunisian Population: Specific Reporting on a Subset of Common Breast Cancer Risk Loci. BMC Cancer (2018) 18(1):1295. 10.1186/s12885-018-5133-8
</cite> [<a href="https://doi.org/10.1186/s12885-018-5133-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6310952/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30594178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=A%20Genome%20Wide%20SNP%20Genotyping%20Study%20in%20the%20Tunisian%20Population:%20Specific%20Reporting%20on%20a%20Subset%20of%20Common%20Breast%20Cancer%20Risk%20Loci&amp;author=Y%20Hamdi&amp;author=M%20Ben%20Rekaya&amp;author=S%20Jingxuan&amp;author=M%20Nagara&amp;author=O%20Messaoud&amp;volume=18&amp;issue=1&amp;publication_year=2018&amp;pages=1295&amp;pmid=30594178&amp;doi=10.1186/s12885-018-5133-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>Hamdi Y, Jerbi M, Romdhane L, Ben Rekaya M, El Benna H, Chouchane L, et al. Genetic Diversity and Functional Effect of Common Polymorphisms in Genes Involved in the First Heterodimeric Complex of the Nucleotide Excision Repair Pathway. DNA Repair (Amst) (2020) 86:102770. 10.1016/j.dnarep.2019.102770
</cite> [<a href="https://doi.org/10.1016/j.dnarep.2019.102770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31865061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=DNA%20Repair%20(Amst)&amp;title=Genetic%20Diversity%20and%20Functional%20Effect%20of%20Common%20Polymorphisms%20in%20Genes%20Involved%20in%20the%20First%20Heterodimeric%20Complex%20of%20the%20Nucleotide%20Excision%20Repair%20Pathway&amp;author=Y%20Hamdi&amp;author=M%20Jerbi&amp;author=L%20Romdhane&amp;author=M%20Ben%20Rekaya&amp;author=H%20El%20Benna&amp;volume=86&amp;publication_year=2020&amp;pages=102770&amp;pmid=31865061&amp;doi=10.1016/j.dnarep.2019.102770&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>Fang M, Zhu L, Li H, Li X, Wu Y, Wu K, et al. Characterization of Mutations in BRCA1/2 and the Relationship With Clinic-Pathological Features of Breast Cancer in a Hereditarily High-Risk Sample of Chinese Population. Oncol Lett (2018) 15(3):3068–74. 10.3892/ol.2017.7717
</cite> [<a href="https://doi.org/10.3892/ol.2017.7717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5778890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29435039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Lett&amp;title=Characterization%20of%20Mutations%20in%20BRCA1/2%20and%20the%20Relationship%20With%20Clinic-Pathological%20Features%20of%20Breast%20Cancer%20in%20a%20Hereditarily%20High-Risk%20Sample%20of%20Chinese%20Population&amp;author=M%20Fang&amp;author=L%20Zhu&amp;author=H%20Li&amp;author=X%20Li&amp;author=Y%20Wu&amp;volume=15&amp;issue=3&amp;publication_year=2018&amp;pmid=29435039&amp;doi=10.3892/ol.2017.7717&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>Godet I, Gilkes DM. BRCA1 and BRCA2 Mutations and Treatment Strategies for Breast Cancer. Integr Cancer Sci Ther (2017) 4(1):10. 10.15761/ICST.1000228
</cite> [<a href="https://doi.org/10.15761/ICST.1000228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5505673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28706734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Integr%20Cancer%20Sci%20Ther&amp;title=BRCA1%20and%20BRCA2%20Mutations%20and%20Treatment%20Strategies%20for%20Breast%20Cancer&amp;author=I%20Godet&amp;author=DM%20Gilkes&amp;volume=4&amp;issue=1&amp;publication_year=2017&amp;pages=10&amp;pmid=28706734&amp;doi=10.15761/ICST.1000228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>Chouchane L, Boussen H, Sastry KSR. Breast Cancer in Arab Populations: Molecular Characteristics and Disease Management Implications. Lancet Oncol (2013) 14(10):e417–e24. 10.1016/S1470-2045(13)70165-7
</cite> [<a href="https://doi.org/10.1016/S1470-2045(13)70165-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23993386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Breast%20Cancer%20in%20Arab%20Populations:%20Molecular%20Characteristics%20and%20Disease%20Management%20Implications&amp;author=L%20Chouchane&amp;author=H%20Boussen&amp;author=KSR%20Sastry&amp;volume=14&amp;issue=10&amp;publication_year=2013&amp;pmid=23993386&amp;doi=10.1016/S1470-2045(13)70165-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>Zehani S, Maalej M, Hsairi M, Hechiche M, Romdhane B, Boussen H, et al. Breast Cancer in Tunisia: Epidemiologic Characteristics and Trends in Incidence. La Tunisie Medicale (2009) 87(7):417–25.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/20063673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=La%20Tunisie%20Medicale&amp;title=Breast%20Cancer%20in%20Tunisia:%20Epidemiologic%20Characteristics%20and%20Trends%20in%20Incidence&amp;author=S%20Zehani&amp;author=M%20Maalej&amp;author=M%20Hsairi&amp;author=M%20Hechiche&amp;author=B%20Romdhane&amp;volume=87&amp;issue=7&amp;publication_year=2009&amp;pmid=20063673&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>Neff RT, Senter L, Salani R. BRCA Mutation in Ovarian Cancer: Testing, Implications and Treatment Considerations. Ther Adv Med Oncol (2017) 9(8):519–31. 10.1177/1758834017714993
</cite> [<a href="https://doi.org/10.1177/1758834017714993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5524247/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28794804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ther%20Adv%20Med%20Oncol&amp;title=BRCA%20Mutation%20in%20Ovarian%20Cancer:%20Testing,%20Implications%20and%20Treatment%20Considerations&amp;author=RT%20Neff&amp;author=L%20Senter&amp;author=R%20Salani&amp;volume=9&amp;issue=8&amp;publication_year=2017&amp;pmid=28794804&amp;doi=10.1177/1758834017714993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>Meindl A, German Consortium for Hereditary B. Ovarian C . Comprehensive Analysis of 989 Patients With Breast or Ovarian Cancer Provides BRCA1 and BRCA2 Mutation Profiles and Frequencies for the German Population. Int J Cancer (2002) 97(4):472–80. 10.1002/ijc.1626
</cite> [<a href="https://doi.org/10.1002/ijc.1626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11802209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=Comprehensive%20Analysis%20of%20989%20Patients%20With%20Breast%20or%20Ovarian%20Cancer%20Provides%20BRCA1%20and%20BRCA2%20Mutation%20Profiles%20and%20Frequencies%20for%20the%20German%20Population&amp;author=A%20Meindl&amp;volume=97&amp;issue=4&amp;publication_year=2002&amp;pmid=11802209&amp;doi=10.1002/ijc.1626&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>Lim MC, Kang S, Seo SS, Kong SY, Lee BY, Lee SK, et al. BRCA1 and BRCA2 Germline Mutations in Korean Ovarian Cancer Patients. J Cancer Res Clin Oncol (2009) 135(11):1593–9. 10.1007/s00432-009-0607-3
</cite> [<a href="https://doi.org/10.1007/s00432-009-0607-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12160277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19499246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin%20Oncol&amp;title=BRCA1%20and%20BRCA2%20Germline%20Mutations%20in%20Korean%20Ovarian%20Cancer%20Patients&amp;author=MC%20Lim&amp;author=S%20Kang&amp;author=SS%20Seo&amp;author=SY%20Kong&amp;author=BY%20Lee&amp;volume=135&amp;issue=11&amp;publication_year=2009&amp;pmid=19499246&amp;doi=10.1007/s00432-009-0607-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>Zuntini R, Cortesi L, Calistri D, Pippucci T, Martelli PL, Casadio R, et al. BRCA1 P. His1673del Is a Pathogenic Mutation Associated With a Predominant Ovarian Cancer Phenotype. Oncotarget (2017) 8(14):22640. 10.18632/oncotarget.15151
</cite> [<a href="https://doi.org/10.18632/oncotarget.15151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5410251/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28186987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=BRCA1%20P.%20His1673del%20Is%20a%20Pathogenic%20Mutation%20Associated%20With%20a%20Predominant%20Ovarian%20Cancer%20Phenotype&amp;author=R%20Zuntini&amp;author=L%20Cortesi&amp;author=D%20Calistri&amp;author=T%20Pippucci&amp;author=PL%20Martelli&amp;volume=8&amp;issue=14&amp;publication_year=2017&amp;pages=22640&amp;pmid=28186987&amp;doi=10.18632/oncotarget.15151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>Cherbal F, Bakour R, Adane S, Boualga K. BRCA1 and BRCA2 Germline Mutation Spectrum in Hereditary Breast/Ovarian Cancer Families From Maghrebian Countries. Breast Dis (2012) 34(1):1–8. 10.3233/BD-130348
</cite> [<a href="https://doi.org/10.3233/BD-130348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23697973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Dis&amp;title=BRCA1%20and%20BRCA2%20Germline%20Mutation%20Spectrum%20in%20Hereditary%20Breast/Ovarian%20Cancer%20Families%20From%20Maghrebian%20Countries&amp;author=F%20Cherbal&amp;author=R%20Bakour&amp;author=S%20Adane&amp;author=K%20Boualga&amp;volume=34&amp;issue=1&amp;publication_year=2012&amp;pages=1-8&amp;pmid=23697973&amp;doi=10.3233/BD-130348&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>Ahn SH, Son BH, Yoon KS, Noh DY, Han W, Kim SW, et al. BRCA1 and BRCA2 Germline Mutations in Korean Breast Cancer Patients at High Risk of Carrying Mutations. Cancer Lett (2007) 245(1-2):90–5. 10.1016/j.canlet.2005.12.031
</cite> [<a href="https://doi.org/10.1016/j.canlet.2005.12.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16455195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=BRCA1%20and%20BRCA2%20Germline%20Mutations%20in%20Korean%20Breast%20Cancer%20Patients%20at%20High%20Risk%20of%20Carrying%20Mutations&amp;author=SH%20Ahn&amp;author=BH%20Son&amp;author=KS%20Yoon&amp;author=DY%20Noh&amp;author=W%20Han&amp;volume=245&amp;issue=1-2&amp;publication_year=2007&amp;pmid=16455195&amp;doi=10.1016/j.canlet.2005.12.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>Kim H, Cho DY, Choi DH, Choi SY, Shin I, Park W, et al. Characteristics and Spectrum of BRCA1 and BRCA2 Mutations in 3,922 Korean Patients With Breast and Ovarian Cancer. Breast Cancer Res Treat (2012) 134(3):1315–26. 10.1007/s10549-012-2159-5
</cite> [<a href="https://doi.org/10.1007/s10549-012-2159-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22798144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Characteristics%20and%20Spectrum%20of%20BRCA1%20and%20BRCA2%20Mutations%20in%203,922%20Korean%20Patients%20With%20Breast%20and%20Ovarian%20Cancer&amp;author=H%20Kim&amp;author=DY%20Cho&amp;author=DH%20Choi&amp;author=SY%20Choi&amp;author=I%20Shin&amp;volume=134&amp;issue=3&amp;publication_year=2012&amp;pmid=22798144&amp;doi=10.1007/s10549-012-2159-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, et al. Prevalence and Type of BRCA Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network. J Clin Oncol (2013) 31(2):210–6. 10.1200/JCO.2011.41.0027
</cite> [<a href="https://doi.org/10.1200/JCO.2011.41.0027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3532393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23233716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Prevalence%20and%20Type%20of%20BRCA%20Mutations%20in%20Hispanics%20Undergoing%20Genetic%20Cancer%20Risk%20Assessment%20in%20the%20Southwestern%20United%20States:%20A%20Report%20From%20the%20Clinical%20Cancer%20Genetics%20Community%20Research%20Network&amp;author=JN%20Weitzel&amp;author=J%20Clague&amp;author=A%20Martir-Negron&amp;author=R%20Ogaz&amp;author=J%20Herzog&amp;volume=31&amp;issue=2&amp;publication_year=2013&amp;pmid=23233716&amp;doi=10.1200/JCO.2011.41.0027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>Torres-Mejia G, Royer R, Llacuachaqui M, Akbari MR, Giuliano AR, Martinez-Matsushita L, et al. Recurrent BRCA1 and BRCA2 Mutations in Mexican Women With Breast Cancer. Cancer Epidemiol Biomarkers Prev (2015) 24(3):498–505. 10.1158/1055-9965.EPI-13-0980
</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-13-0980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4495576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25371446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Recurrent%20BRCA1%20and%20BRCA2%20Mutations%20in%20Mexican%20Women%20With%20Breast%20Cancer&amp;author=G%20Torres-Mejia&amp;author=R%20Royer&amp;author=M%20Llacuachaqui&amp;author=MR%20Akbari&amp;author=AR%20Giuliano&amp;volume=24&amp;issue=3&amp;publication_year=2015&amp;pages=498-505&amp;pmid=25371446&amp;doi=10.1158/1055-9965.EPI-13-0980&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>Palmero EI, Carraro DM, Alemar B, Moreira MAM, Ribeiro-Dos-Santos A, Abe-Sandes K, et al. The Germline Mutational Landscape of BRCA1 and BRCA2 in Brazil. Sci Rep (2018) 8(1):9188. 10.1038/s41598-018-27315-2
</cite> [<a href="https://doi.org/10.1038/s41598-018-27315-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6003960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29907814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=The%20Germline%20Mutational%20Landscape%20of%20BRCA1%20and%20BRCA2%20in%20Brazil&amp;author=EI%20Palmero&amp;author=DM%20Carraro&amp;author=B%20Alemar&amp;author=MAM%20Moreira&amp;author=A%20Ribeiro-Dos-Santos&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=9188&amp;pmid=29907814&amp;doi=10.1038/s41598-018-27315-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<span class="label">49.</span><cite>Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, et al. The Yield of Full BRCA1/2 Genotyping in Israeli High-Risk Breast/Ovarian Cancer Patients Who Do Not Carry the Predominant Mutations. Breast Cancer Res Treat (2018) 172(1):151–7. 10.1007/s10549-018-4887-7
</cite> [<a href="https://doi.org/10.1007/s10549-018-4887-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30014164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=The%20Yield%20of%20Full%20BRCA1/2%20Genotyping%20in%20Israeli%20High-Risk%20Breast/Ovarian%20Cancer%20Patients%20Who%20Do%20Not%20Carry%20the%20Predominant%20Mutations&amp;author=I%20Barnes-Kedar&amp;author=R%20Bernstein-Molho&amp;author=N%20Ginzach&amp;author=S%20Hartmajer&amp;author=T%20Shapira&amp;volume=172&amp;issue=1&amp;publication_year=2018&amp;pmid=30014164&amp;doi=10.1007/s10549-018-4887-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<span class="label">50.</span><cite>Jakimovska M, Maleva Kostovska I, Popovska-Jankovic K, Kubelka-Sabit K, Karadjozov M, Stojanovska L, et al. BRCA1 and BRCA2 Germline Variants in Breast Cancer Patients From the Republic of Macedonia. Breast Cancer Res Treat (2018) 168(3):745–53. 10.1007/s10549-017-4642-5
</cite> [<a href="https://doi.org/10.1007/s10549-017-4642-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29335924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=BRCA1%20and%20BRCA2%20Germline%20Variants%20in%20Breast%20Cancer%20Patients%20From%20the%20Republic%20of%20Macedonia&amp;author=M%20Jakimovska&amp;author=I%20Maleva%20Kostovska&amp;author=K%20Popovska-Jankovic&amp;author=K%20Kubelka-Sabit&amp;author=M%20Karadjozov&amp;volume=168&amp;issue=3&amp;publication_year=2018&amp;pmid=29335924&amp;doi=10.1007/s10549-017-4642-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<span class="label">51.</span><cite>Mighri N, Hamdi Y, Boujemaa M, Othman H, Ben Nasr S, El Benna H, et al. Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients. Front Genet (2020) 11:552971. 10.3389/fgene.2020.552971
</cite> [<a href="https://doi.org/10.3389/fgene.2020.552971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7677579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33240314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=Identification%20of%20Novel%20BRCA1%20and%20RAD50%20Mutations%20Associated%20With%20Breast%20Cancer%20Predisposition%20in%20Tunisian%20Patients&amp;author=N%20Mighri&amp;author=Y%20Hamdi&amp;author=M%20Boujemaa&amp;author=H%20Othman&amp;author=S%20Ben%20Nasr&amp;volume=11&amp;publication_year=2020&amp;pages=552971&amp;pmid=33240314&amp;doi=10.3389/fgene.2020.552971&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<span class="label">52.</span><cite>Manchana T, Phoolcharoen N, Tantbirojn P. BRCA Mutation in High Grade Epithelial Ovarian Cancers. Gynecol Oncol Rep (2019) 29:102–5. 10.1016/j.gore.2019.07.007
</cite> [<a href="https://doi.org/10.1016/j.gore.2019.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6710551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31467961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol%20Rep&amp;title=BRCA%20Mutation%20in%20High%20Grade%20Epithelial%20Ovarian%20Cancers&amp;author=T%20Manchana&amp;author=N%20Phoolcharoen&amp;author=P%20Tantbirojn&amp;volume=29&amp;publication_year=2019&amp;pmid=31467961&amp;doi=10.1016/j.gore.2019.07.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<span class="label">53.</span><cite>Hamel N, Feng BJ, Foretova L, Stoppa-Lyonnet D, Narod SA, Imyanitov E, et al. On the Origin and Diffusion of BRCA1 C.5266dupc (5382insc) in European Populations. Eur J Hum Genet (2011) 19(3):300–6. 10.1038/ejhg.2010.203
</cite> [<a href="https://doi.org/10.1038/ejhg.2010.203" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3062007/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21119707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Hum%20Genet&amp;title=On%20the%20Origin%20and%20Diffusion%20of%20BRCA1%20C.5266dupc%20(5382insc)%20in%20European%20Populations&amp;author=N%20Hamel&amp;author=BJ%20Feng&amp;author=L%20Foretova&amp;author=D%20Stoppa-Lyonnet&amp;author=SA%20Narod&amp;volume=19&amp;issue=3&amp;publication_year=2011&amp;pmid=21119707&amp;doi=10.1038/ejhg.2010.203&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<span class="label">54.</span><cite>Janavicius R. Founder BRCA1/2 Mutations in the Europe: Implications for Hereditary Breast-Ovarian Cancer Prevention and Control. EPMA J (2010) 1(3):397–412. 10.1007/s13167-010-0037-y
</cite> [<a href="https://doi.org/10.1007/s13167-010-0037-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3405339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23199084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EPMA%20J&amp;title=Founder%20BRCA1/2%20Mutations%20in%20the%20Europe:%20Implications%20for%20Hereditary%20Breast-Ovarian%20Cancer%20Prevention%20and%20Control&amp;author=R%20Janavicius&amp;volume=1&amp;issue=3&amp;publication_year=2010&amp;pages=397-412&amp;pmid=23199084&amp;doi=10.1007/s13167-010-0037-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<span class="label">55.</span><cite>Edwards SM, Evans DGR, Hope Q, Norman A, Barbachano Y, Bullock S, et al. Prostate Cancer in BRCA2 Germline Mutation Carriers is Associated With Poorer Prognosis. Br J Cancer (2010) 103(6):918–24. 10.1038/sj.bjc.6605822
</cite> [<a href="https://doi.org/10.1038/sj.bjc.6605822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2948551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20736950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=Prostate%20Cancer%20in%20BRCA2%20Germline%20Mutation%20Carriers%20is%20Associated%20With%20Poorer%20Prognosis&amp;author=SM%20Edwards&amp;author=DGR%20Evans&amp;author=Q%20Hope&amp;author=A%20Norman&amp;author=Y%20Barbachano&amp;volume=103&amp;issue=6&amp;publication_year=2010&amp;pmid=20736950&amp;doi=10.1038/sj.bjc.6605822&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<span class="label">56.</span><cite>Laarabi FZ, Ratbi I, Elalaoui SC, Mezzouar L, Doubaj Y, Bouguenouch L, et al. High Frequency of the Recurrent C.1310_1313delaaga BRCA2 Mutation in the North-East of Morocco and Implication for Hereditary Breast-Ovarian Cancer Prevention and Control. BMC Res Notes (2017) 10(1):188. 10.1186/s13104-017-2511-2
</cite> [<a href="https://doi.org/10.1186/s13104-017-2511-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5457611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28577564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Res%20Notes&amp;title=High%20Frequency%20of%20the%20Recurrent%20C.1310_1313delaaga%20BRCA2%20Mutation%20in%20the%20North-East%20of%20Morocco%20and%20Implication%20for%20Hereditary%20Breast-Ovarian%20Cancer%20Prevention%20and%20Control&amp;author=FZ%20Laarabi&amp;author=I%20Ratbi&amp;author=SC%20Elalaoui&amp;author=L%20Mezzouar&amp;author=Y%20Doubaj&amp;volume=10&amp;issue=1&amp;publication_year=2017&amp;pages=188&amp;pmid=28577564&amp;doi=10.1186/s13104-017-2511-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<span class="label">57.</span><cite>Cherbal F, Bakour R, Adane S, Boualga K, Benais-Pont G, Maillet P. BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families. Dis Markers (2010) 28(6):377–84. 10.1155/2010/585278
</cite> [<a href="https://doi.org/10.1155/2010/585278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3833328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20683152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis%20Markers&amp;title=BRCA1%20and%20BRCA2%20Germline%20Mutations%20Screening%20in%20Algerian%20Breast/Ovarian%20Cancer%20Families&amp;author=F%20Cherbal&amp;author=R%20Bakour&amp;author=S%20Adane&amp;author=K%20Boualga&amp;author=G%20Benais-Pont&amp;volume=28&amp;issue=6&amp;publication_year=2010&amp;pmid=20683152&amp;doi=10.1155/2010/585278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<span class="label">58.</span><cite>El Saghir NS, Zgheib NK, Assi HA, Khoury KE, Bidet Y, Jaber SM, et al. BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer. Oncologist (2015) 20(4):357–64. 10.1634/theoncologist.2014-0364
</cite> [<a href="https://doi.org/10.1634/theoncologist.2014-0364" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4391767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25777348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncologist&amp;title=BRCA1%20and%20BRCA2%20Mutations%20in%20Ethnic%20Lebanese%20Arab%20Women%20With%20High%20Hereditary%20Risk%20Breast%20Cancer&amp;author=NS%20El%20Saghir&amp;author=NK%20Zgheib&amp;author=HA%20Assi&amp;author=KE%20Khoury&amp;author=Y%20Bidet&amp;volume=20&amp;issue=4&amp;publication_year=2015&amp;pmid=25777348&amp;doi=10.1634/theoncologist.2014-0364&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<span class="label">59.</span><cite>Caputo S, Benboudjema L, Sinilnikova O, Rouleau E, Beroud C, Lidereau R, et al. Description and Analysis of Genetic Variants in French Hereditary Breast and Ovarian Cancer Families Recorded in the UMD-BRCA1/BRCA2 Databases. Nucleic Acids Res (2012) 40(Database issue):D992–1002. 10.1093/nar/gkr1160
</cite> [<a href="https://doi.org/10.1093/nar/gkr1160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3245050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22144684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=Description%20and%20Analysis%20of%20Genetic%20Variants%20in%20French%20Hereditary%20Breast%20and%20Ovarian%20Cancer%20Families%20Recorded%20in%20the%20UMD-BRCA1/BRCA2%20Databases&amp;author=S%20Caputo&amp;author=L%20Benboudjema&amp;author=O%20Sinilnikova&amp;author=E%20Rouleau&amp;author=C%20Beroud&amp;volume=40&amp;issue=Database%20issue&amp;publication_year=2012&amp;pages=D992-1002&amp;pmid=22144684&amp;doi=10.1093/nar/gkr1160&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<span class="label">60.</span><cite>Vos JR, Teixeira N, van der Kolk DM, Mourits MJ, Rookus MA, van Leeuwen FE, et al. Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands. Cancer Epidemiol Biomarkers Prev (2014) 23(11):2482–91. 10.1158/1055-9965.EPI-13-1279
</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-13-1279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25103822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Variation%20in%20Mutation%20Spectrum%20Partly%20Explains%20Regional%20Differences%20in%20the%20Breast%20Cancer%20Risk%20of%20Female%20BRCA%20Mutation%20Carriers%20in%20the%20Netherlands&amp;author=JR%20Vos&amp;author=N%20Teixeira&amp;author=DM%20van%20der%20Kolk&amp;author=MJ%20Mourits&amp;author=MA%20Rookus&amp;volume=23&amp;issue=11&amp;publication_year=2014&amp;pmid=25103822&amp;doi=10.1158/1055-9965.EPI-13-1279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<span class="label">61.</span><cite>Meisel C, Sadowski CE, Kohlstedt D, Keller K, Staritz F, Grubling N, et al. Spectrum of Genetic Variants of BRCA1 and BRCA2 in a German Single Center Study. Arch Gynecol Obstet (2017) 295(5):1227–38. 10.1007/s00404-017-4330-z
</cite> [<a href="https://doi.org/10.1007/s00404-017-4330-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28324225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Gynecol%20Obstet&amp;title=Spectrum%20of%20Genetic%20Variants%20of%20BRCA1%20and%20BRCA2%20in%20a%20German%20Single%20Center%20Study&amp;author=C%20Meisel&amp;author=CE%20Sadowski&amp;author=D%20Kohlstedt&amp;author=K%20Keller&amp;author=F%20Staritz&amp;volume=295&amp;issue=5&amp;publication_year=2017&amp;pmid=28324225&amp;doi=10.1007/s00404-017-4330-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<span class="label">62.</span><cite>Thomassen M, Hansen TV, Borg A, Lianee HT, Wikman F, Pedersen IS, et al. BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer. Acta Oncol (2008) 47(4):772–7. 10.1080/02841860802004974
</cite> [<a href="https://doi.org/10.1080/02841860802004974" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18465347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncol&amp;title=BRCA1%20and%20BRCA2%20Mutations%20in%20Danish%20Families%20With%20Hereditary%20Breast%20and/or%20Ovarian%20Cancer&amp;author=M%20Thomassen&amp;author=TV%20Hansen&amp;author=A%20Borg&amp;author=HT%20Lianee&amp;author=F%20Wikman&amp;volume=47&amp;issue=4&amp;publication_year=2008&amp;pmid=18465347&amp;doi=10.1080/02841860802004974&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63">
<span class="label">63.</span><cite>Zhang J, Fackenthal JD, Zheng Y, Huo D, Hou N, Niu Q, et al. Recurrent BRCA1 and BRCA2 Mutations in Breast Cancer Patients of African Ancestry. Breast Cancer Res Treat (2012) 134(2):889–94. 10.1007/s10549-012-2136-z
</cite> [<a href="https://doi.org/10.1007/s10549-012-2136-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22739995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Recurrent%20BRCA1%20and%20BRCA2%20Mutations%20in%20Breast%20Cancer%20Patients%20of%20African%20Ancestry&amp;author=J%20Zhang&amp;author=JD%20Fackenthal&amp;author=Y%20Zheng&amp;author=D%20Huo&amp;author=N%20Hou&amp;volume=134&amp;issue=2&amp;publication_year=2012&amp;pmid=22739995&amp;doi=10.1007/s10549-012-2136-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64">
<span class="label">64.</span><cite>Jang JH, Lee JE, Kwon MJ, Ki CS, Kim JW, Nam SJ, et al. Spectra of BRCA1 and BRCA2 Mutations in Korean Patients With Breast Cancer: The Importance of Whole-Gene Sequencing. J Hum Genet (2012) 57(3):212–5. 10.1038/jhg.2011.139
</cite> [<a href="https://doi.org/10.1038/jhg.2011.139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22217648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hum%20Genet&amp;title=Spectra%20of%20BRCA1%20and%20BRCA2%20Mutations%20in%20Korean%20Patients%20With%20Breast%20Cancer:%20The%20Importance%20of%20Whole-Gene%20Sequencing&amp;author=JH%20Jang&amp;author=JE%20Lee&amp;author=MJ%20Kwon&amp;author=CS%20Ki&amp;author=JW%20Kim&amp;volume=57&amp;issue=3&amp;publication_year=2012&amp;pmid=22217648&amp;doi=10.1038/jhg.2011.139&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65">
<span class="label">65.</span><cite>Cruz-Correa M, Perez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Roman K, et al. Hereditary Cancer Syndromes in Latino Populations: Genetic Characterization and Surveillance Guidelines. Hered Cancer Clin Pract (2017) 15:3. 10.1186/s13053-017-0063-z
</cite> [<a href="https://doi.org/10.1186/s13053-017-0063-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5251307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28127413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hered%20Cancer%20Clin%20Pract&amp;title=Hereditary%20Cancer%20Syndromes%20in%20Latino%20Populations:%20Genetic%20Characterization%20and%20Surveillance%20Guidelines&amp;author=M%20Cruz-Correa&amp;author=J%20Perez-Mayoral&amp;author=J%20Dutil&amp;author=M%20Echenique&amp;author=R%20Mosquera&amp;volume=15&amp;publication_year=2017&amp;pages=3&amp;pmid=28127413&amp;doi=10.1186/s13053-017-0063-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66">
<span class="label">66.</span><cite>Akbari MR, Donenberg T, Lunn J, Curling D, Turnquest T, Krill-Jackson E, et al. The Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer Patients in the Bahamas. Clin Genet (2014) 85(1):64–7. 10.1111/cge.12132
</cite> [<a href="https://doi.org/10.1111/cge.12132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23458327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Genet&amp;title=The%20Spectrum%20of%20BRCA1%20and%20BRCA2%20Mutations%20in%20Breast%20Cancer%20Patients%20in%20the%20Bahamas&amp;author=MR%20Akbari&amp;author=T%20Donenberg&amp;author=J%20Lunn&amp;author=D%20Curling&amp;author=T%20Turnquest&amp;volume=85&amp;issue=1&amp;publication_year=2014&amp;pmid=23458327&amp;doi=10.1111/cge.12132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67">
<span class="label">67.</span><cite>Donenberg T, Ahmed H, Royer R, Zhang S, Narod SA, George S, et al. A Survey of BRCA1, BRCA2, and PALB2 Mutations in Women With Breast Cancer in Trinidad and Tobago. Breast Cancer Res Treat (2016) 159(1):131–8. 10.1007/s10549-016-3870-4
</cite> [<a href="https://doi.org/10.1007/s10549-016-3870-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27469594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=A%20Survey%20of%20BRCA1,%20BRCA2,%20and%20PALB2%20Mutations%20in%20Women%20With%20Breast%20Cancer%20in%20Trinidad%20and%20Tobago&amp;author=T%20Donenberg&amp;author=H%20Ahmed&amp;author=R%20Royer&amp;author=S%20Zhang&amp;author=SA%20Narod&amp;volume=159&amp;issue=1&amp;publication_year=2016&amp;pmid=27469594&amp;doi=10.1007/s10549-016-3870-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68">
<span class="label">68.</span><cite>Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, et al. Male Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: Pathology Data From the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res (2016) 18(1):15. 10.1186/s13058-016-0671-y
</cite> [<a href="https://doi.org/10.1186/s13058-016-0671-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4746828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26857456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=Male%20Breast%20Cancer%20in%20BRCA1%20and%20BRCA2%20Mutation%20Carriers:%20Pathology%20Data%20From%20the%20Consortium%20of%20Investigators%20of%20Modifiers%20of%20BRCA1/2&amp;author=V%20Silvestri&amp;author=D%20Barrowdale&amp;author=AM%20Mulligan&amp;author=SL%20Neuhausen&amp;author=S%20Fox&amp;volume=18&amp;issue=1&amp;publication_year=2016&amp;pages=15&amp;pmid=26857456&amp;doi=10.1186/s13058-016-0671-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69">
<span class="label">69.</span><cite>Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, et al. Haplotype and Phenotype Analysis of Six Recurrent BRCA1 Mutations in 61 Families: Results of an International Study. Am J Hum Genet (1996) 58(2):271.
</cite> [<a href="/articles/PMC1914544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8571953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Haplotype%20and%20Phenotype%20Analysis%20of%20Six%20Recurrent%20BRCA1%20Mutations%20in%2061%20Families:%20Results%20of%20an%20International%20Study&amp;author=SL%20Neuhausen&amp;author=S%20Mazoyer&amp;author=L%20Friedman&amp;author=M%20Stratton&amp;author=K%20Offit&amp;volume=58&amp;issue=2&amp;publication_year=1996&amp;pages=271&amp;pmid=8571953&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70">
<span class="label">70.</span><cite>Henouda S, Bensalem A, Reggad R, Serrar N, Rouabah L, Pujol P. Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer. Dis Markers (2016) 2016:7869095. 10.1155/2016/7869095
</cite> [<a href="https://doi.org/10.1155/2016/7869095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4779828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26997744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis%20Markers&amp;title=Contribution%20of%20BRCA1%20and%20BRCA2%20Germline%20Mutations%20to%20Early%20Algerian%20Breast%20Cancer&amp;author=S%20Henouda&amp;author=A%20Bensalem&amp;author=R%20Reggad&amp;author=N%20Serrar&amp;author=L%20Rouabah&amp;volume=2016&amp;publication_year=2016&amp;pages=7869095&amp;pmid=26997744&amp;doi=10.1155/2016/7869095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71">
<span class="label">71.</span><cite>Veronesi A, de Giacomi C, Magri MD, Lombardi D, Zanetti M, Scuderi C, et al. Familial Breast Cancer: Characteristics and Outcome of BRCA 1-2 Positive and Negative Cases. BMC Cancer (2005) 5:70. 10.1186/1471-2407-5-70
</cite> [<a href="https://doi.org/10.1186/1471-2407-5-70" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1184063/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15996267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Familial%20Breast%20Cancer:%20Characteristics%20and%20Outcome%20of%20BRCA%201-2%20Positive%20and%20Negative%20Cases&amp;author=A%20Veronesi&amp;author=C%20de%20Giacomi&amp;author=MD%20Magri&amp;author=D%20Lombardi&amp;author=M%20Zanetti&amp;volume=5&amp;publication_year=2005&amp;pages=70&amp;pmid=15996267&amp;doi=10.1186/1471-2407-5-70&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72">
<span class="label">72.</span><cite>Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, et al. Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer. J Clin Oncol (2008) 26(26):4282–8. 10.1200/JCO.2008.16.6231
</cite> [<a href="https://doi.org/10.1200/JCO.2008.16.6231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6366335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18779615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Clinical%20and%20Pathologic%20Characteristics%20of%20Patients%20With%20BRCA-Positive%20and%20BRCA-Negative%20Breast%20Cancer&amp;author=DP%20Atchley&amp;author=CT%20Albarracin&amp;author=A%20Lopez&amp;author=V%20Valero&amp;author=CI%20Amos&amp;volume=26&amp;issue=26&amp;publication_year=2008&amp;pmid=18779615&amp;doi=10.1200/JCO.2008.16.6231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73">
<span class="label">73.</span><cite>Jouhadi H, Tazzite A, Azeddoug H, Naim A, Nadifi S, Benider A. Clinical and Pathological Features of BRCA1/2 Tumors in a Sample of High-Risk Moroccan Breast Cancer Patients. BMC Res Notes (2016) 9:248. 10.1186/s13104-016-2057-8
</cite> [<a href="https://doi.org/10.1186/s13104-016-2057-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4850715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27129401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Res%20Notes&amp;title=Clinical%20and%20Pathological%20Features%20of%20BRCA1/2%20Tumors%20in%20a%20Sample%20of%20High-Risk%20Moroccan%20Breast%20Cancer%20Patients&amp;author=H%20Jouhadi&amp;author=A%20Tazzite&amp;author=H%20Azeddoug&amp;author=A%20Naim&amp;author=S%20Nadifi&amp;volume=9&amp;publication_year=2016&amp;pages=248&amp;pmid=27129401&amp;doi=10.1186/s13104-016-2057-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74">
<span class="label">74.</span><cite>Atci MM, Geredeli C, Ay S, Sakin A, Erturk B, Secmeler S, et al. Clinical and Pathological Characteristics of Patients With High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study. Eur J Breast Health (2021) 17(2):123–7. 10.4274/ejbh.galenos.2020.6346
</cite> [<a href="https://doi.org/10.4274/ejbh.galenos.2020.6346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8025729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33870111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Breast%20Health&amp;title=Clinical%20and%20Pathological%20Characteristics%20of%20Patients%20With%20High-Risk%20Breast%20Cancer%20Based%20on%20BRCA%20Mutation%20Profiles:%20A%20Retrospective%20Study&amp;author=MM%20Atci&amp;author=C%20Geredeli&amp;author=S%20Ay&amp;author=A%20Sakin&amp;author=B%20Erturk&amp;volume=17&amp;issue=2&amp;publication_year=2021&amp;pmid=33870111&amp;doi=10.4274/ejbh.galenos.2020.6346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75">
<span class="label">75.</span><cite>Lee E, McKean-Cowdin R, Ma H, Spicer DV, Van Den Berg D, Bernstein L, et al. Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women. J Clin Oncol (2011) 29(33):4373–80. 10.1200/JCO.2010.33.6446
</cite> [<a href="https://doi.org/10.1200/JCO.2010.33.6446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3221522/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22010008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Characteristics%20of%20Triple-Negative%20Breast%20Cancer%20in%20Patients%20With%20a%20BRCA1%20Mutation:%20Results%20From%20a%20Population-Based%20Study%20of%20Young%20Women&amp;author=E%20Lee&amp;author=R%20McKean-Cowdin&amp;author=H%20Ma&amp;author=DV%20Spicer&amp;author=D%20Van%20Den%20Berg&amp;volume=29&amp;issue=33&amp;publication_year=2011&amp;pmid=22010008&amp;doi=10.1200/JCO.2010.33.6446&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76">
<span class="label">76.</span><cite>Muendlein A, Rohde BH, Gasser K, Haid A, Rauch S, Kinz E, et al. Evaluation of BRCA1/2 Mutational Status Among German and Austrian Women With Triple-Negative Breast Cancer. J Cancer Res Clin Oncol (2015) 141(11):2005–12. 10.1007/s00432-015-1986-2
</cite> [<a href="https://doi.org/10.1007/s00432-015-1986-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11823898/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25971625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin%20Oncol&amp;title=Evaluation%20of%20BRCA1/2%20Mutational%20Status%20Among%20German%20and%20Austrian%20Women%20With%20Triple-Negative%20Breast%20Cancer&amp;author=A%20Muendlein&amp;author=BH%20Rohde&amp;author=K%20Gasser&amp;author=A%20Haid&amp;author=S%20Rauch&amp;volume=141&amp;issue=11&amp;publication_year=2015&amp;pmid=25971625&amp;doi=10.1007/s00432-015-1986-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77">
<span class="label">77.</span><cite>Stefansson OA, Jonasson JG, Olafsdottir K, Bjarnason H, Th Johannsson O, Bodvarsdottir SK, et al. Genomic and Phenotypic Analysis of BRCA2 Mutated Breast Cancers Reveals Co-Occurring Changes Linked to Progression. Breast Cancer Res (2011) 13(5):R95. 10.1186/bcr3020
</cite> [<a href="https://doi.org/10.1186/bcr3020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3262207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21958427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=Genomic%20and%20Phenotypic%20Analysis%20of%20BRCA2%20Mutated%20Breast%20Cancers%20Reveals%20Co-Occurring%20Changes%20Linked%20to%20Progression&amp;author=OA%20Stefansson&amp;author=JG%20Jonasson&amp;author=K%20Olafsdottir&amp;author=H%20Bjarnason&amp;author=O%20Th%20Johannsson&amp;volume=13&amp;issue=5&amp;publication_year=2011&amp;pages=R95&amp;pmid=21958427&amp;doi=10.1186/bcr3020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78">
<span class="label">78.</span><cite>Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, et al. Prediction of BRCA1 Status in Patients With Breast Cancer Using Estrogen Receptor and Basal Phenotype. Clin Cancer Res (2005) 11(14):5175–80. 10.1158/1078-0432.CCR-04-2424
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-04-2424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16033833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Prediction%20of%20BRCA1%20Status%20in%20Patients%20With%20Breast%20Cancer%20Using%20Estrogen%20Receptor%20and%20Basal%20Phenotype&amp;author=SR%20Lakhani&amp;author=JS%20Reis-Filho&amp;author=L%20Fulford&amp;author=F%20Penault-Llorca&amp;author=M%20van%20der%20Vijver&amp;volume=11&amp;issue=14&amp;publication_year=2005&amp;pmid=16033833&amp;doi=10.1158/1078-0432.CCR-04-2424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79">
<span class="label">79.</span><cite>Keeney MG, Couch FJ, Visscher DW, Lindor NM. Non-BRCA Familial Breast Cancer: Review of Reported Pathology and Molecular Findings. Pathology (2017) 49(4):363–70. 10.1016/j.pathol.2017.03.002
</cite> [<a href="https://doi.org/10.1016/j.pathol.2017.03.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28450088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathology&amp;title=Non-BRCA%20Familial%20Breast%20Cancer:%20Review%20of%20Reported%20Pathology%20and%20Molecular%20Findings&amp;author=MG%20Keeney&amp;author=FJ%20Couch&amp;author=DW%20Visscher&amp;author=NM%20Lindor&amp;volume=49&amp;issue=4&amp;publication_year=2017&amp;pmid=28450088&amp;doi=10.1016/j.pathol.2017.03.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80">
<span class="label">80.</span><cite>Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, et al. Frequencies of BRCA1 and BRCA2 Mutations Among 1,342 Unselected Patients With Invasive Ovarian Cancer. Gynecol Oncol (2011) 121(2):353–7. 10.1016/j.ygyno.2011.01.020
</cite> [<a href="https://doi.org/10.1016/j.ygyno.2011.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21324516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Frequencies%20of%20BRCA1%20and%20BRCA2%20Mutations%20Among%201,342%20Unselected%20Patients%20With%20Invasive%20Ovarian%20Cancer&amp;author=S%20Zhang&amp;author=R%20Royer&amp;author=S%20Li&amp;author=JR%20McLaughlin&amp;author=B%20Rosen&amp;volume=121&amp;issue=2&amp;publication_year=2011&amp;pmid=21324516&amp;doi=10.1016/j.ygyno.2011.01.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81">
<span class="label">81.</span><cite>Lang GT, Shi JX, Hu X, Zhang CH, Shan L, Song CG, et al. The Spectrum of BRCA Mutations and Characteristics of BRCA-Associated Breast Cancers in China: Screening of 2,991 Patients and 1,043 Controls by Next-Generation Sequencing. Int J Cancer (2017) 141(1):129–42. 10.1002/ijc.30692
</cite> [<a href="https://doi.org/10.1002/ijc.30692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28294317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=The%20Spectrum%20of%20BRCA%20Mutations%20and%20Characteristics%20of%20BRCA-Associated%20Breast%20Cancers%20in%20China:%20Screening%20of%202,991%20Patients%20and%201,043%20Controls%20by%20Next-Generation%20Sequencing&amp;author=GT%20Lang&amp;author=JX%20Shi&amp;author=X%20Hu&amp;author=CH%20Zhang&amp;author=L%20Shan&amp;volume=141&amp;issue=1&amp;publication_year=2017&amp;pmid=28294317&amp;doi=10.1002/ijc.30692&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82">
<span class="label">82.</span><cite>Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama (2017) 317(23):2402–16. 10.1001/jama.2017.7112
</cite> [<a href="https://doi.org/10.1001/jama.2017.7112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jama&amp;title=Risks%20of%20Breast,%20Ovarian,%20and%20Contralateral%20Breast%20Cancer%20for%20BRCA1%20and%20BRCA2%20Mutation%20Carriers&amp;author=KB%20Kuchenbaecker&amp;author=JL%20Hopper&amp;author=DR%20Barnes&amp;author=K-A%20Phillips&amp;author=TM%20Mooij&amp;volume=317&amp;issue=23&amp;publication_year=2017&amp;pmid=28632866&amp;doi=10.1001/jama.2017.7112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83">
<span class="label">83.</span><cite>Einbeigi Z, Bergman A, Meis-Kindblom JM, Flodin A, Bjursell C, Martinsson T, et al. Occurrence of Both Breast and Ovarian Cancer in a Woman Is a Marker for the BRCA Gene Mutations: A Population-Based Study From Western Sweden. Familial Cancer (2007) 6(1):35–41. 10.1007/s10689-006-9101-0
</cite> [<a href="https://doi.org/10.1007/s10689-006-9101-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16944270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Familial%20Cancer&amp;title=Occurrence%20of%20Both%20Breast%20and%20Ovarian%20Cancer%20in%20a%20Woman%20Is%20a%20Marker%20for%20the%20BRCA%20Gene%20Mutations:%20A%20Population-Based%20Study%20From%20Western%20Sweden&amp;author=Z%20Einbeigi&amp;author=A%20Bergman&amp;author=JM%20Meis-Kindblom&amp;author=A%20Flodin&amp;author=C%20Bjursell&amp;volume=6&amp;issue=1&amp;publication_year=2007&amp;pages=35-41&amp;pmid=16944270&amp;doi=10.1007/s10689-006-9101-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84">
<span class="label">84.</span><cite>Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the Missing Heritability of Complex Diseases. Nature (2009) 461(7265):747–53. 10.1038/nature08494
</cite> [<a href="https://doi.org/10.1038/nature08494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2831613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19812666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Finding%20the%20Missing%20Heritability%20of%20Complex%20Diseases&amp;author=TA%20Manolio&amp;author=FS%20Collins&amp;author=NJ%20Cox&amp;author=DB%20Goldstein&amp;author=LA%20Hindorff&amp;volume=461&amp;issue=7265&amp;publication_year=2009&amp;pmid=19812666&amp;doi=10.1038/nature08494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85">
<span class="label">85.</span><cite>Lesage S, Belarbi S, Troiano A, Condroyer C, Hecham N, Pollak P, et al. Is the Common LRRK2 G2019S Mutation Related to Dyskinesias in North African Parkinson Disease? Neurology (2008) 71(19):1550–2. 10.1212/01.wnl.0000338460.89796.06
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000338460.89796.06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18981379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Is%20the%20Common%20LRRK2%20G2019S%20Mutation%20Related%20to%20Dyskinesias%20in%20North%20African%20Parkinson%20Disease&amp;author=S%20Lesage&amp;author=S%20Belarbi&amp;author=A%20Troiano&amp;author=C%20Condroyer&amp;author=N%20Hecham&amp;volume=71&amp;issue=19&amp;publication_year=2008&amp;pmid=18981379&amp;doi=10.1212/01.wnl.0000338460.89796.06&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B86">
<span class="label">86.</span><cite>Hulihan MM, Ishihara-Paul L, Kachergus J, Warren L, Amouri R, Elango R, et al. LRRK2 Gly2019Ser Penetrance in Arab-Berber Patients From Tunisia: A Case-Control Genetic Study. Lancet Neurol (2008) 7(7):591–4. 10.1016/S1474-4422(08)70116-9
</cite> [<a href="https://doi.org/10.1016/S1474-4422(08)70116-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18539535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Neurol&amp;title=LRRK2%20Gly2019Ser%20Penetrance%20in%20Arab-Berber%20Patients%20From%20Tunisia:%20A%20Case-Control%20Genetic%20Study&amp;author=MM%20Hulihan&amp;author=L%20Ishihara-Paul&amp;author=J%20Kachergus&amp;author=L%20Warren&amp;author=R%20Amouri&amp;volume=7&amp;issue=7&amp;publication_year=2008&amp;pmid=18539535&amp;doi=10.1016/S1474-4422(08)70116-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B87">
<span class="label">87.</span><cite>Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE, et al. An International Initiative to Identify Genetic Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res (2007) 9(2):104. 10.1186/bcr1670
</cite> [<a href="https://doi.org/10.1186/bcr1670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1868919/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17466083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=An%20International%20Initiative%20to%20Identify%20Genetic%20Modifiers%20of%20Cancer%20Risk%20in%20BRCA1%20and%20BRCA2%20Mutation%20Carriers:%20The%20Consortium%20of%20Investigators%20of%20Modifiers%20of%20BRCA1%20and%20BRCA2%20(CIMBA)&amp;author=G%20Chenevix-Trench&amp;author=RL%20Milne&amp;author=AC%20Antoniou&amp;author=FJ%20Couch&amp;author=DF%20Easton&amp;volume=9&amp;issue=2&amp;publication_year=2007&amp;pages=104&amp;pmid=17466083&amp;doi=10.1186/bcr1670&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8417726/bin/Table_1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (659.1KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in this study are included in this article and in its supplementary files. All identified mutations with their related details have been shared in the public database ClinVar under the following link “<a href="https://www.ncbi.nlm.nih.gov/clinvar/submitters/507986/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/submitters/507986/</a>”. Any additional datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Oncology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fonc.2021.674965"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fonc-11-674965.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8417726/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8417726/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8417726%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8417726/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8417726/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8417726/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/34490083/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8417726/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/34490083/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8417726/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8417726/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="NyujS4pxjf0fsrbFTf9gM5GTUiNE09mOpIUwEWS5AXuzDxGG9exQjdzz1acR3URj">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
